Connective tissue disorder
MONDO:0003900A disease involving the connective tissue.
Also known as: connective tissue disease, connective tissue disease or disorder, connective tissue diseases, connective tissue disorder, connective tissue disorders, disease of connective tissue, disease or disorder of connective tissue, disease, connective tissue
4076 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
Showing the 400 most recently updated of 842 trials in this tab.
-
HPV vaccine shows promise for girls on Immune-Suppressing drugs
⭐️ VACCINE ⭐️ CompletedThis study looked at whether the HPV vaccine works in girls aged 9 to 17 who are taking medicines that weaken their immune system, such as after an organ transplant or for diseases like lupus. The goal was to see if their bodies produce enough antibodies to protect against HPV. T…
Phase: PHASE2 • Sponsor: University Hospital, Bordeaux • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:36 UTC
-
Shingles vaccine study shows promise for rheumatoid arthritis patients
⭐️ VACCINE ⭐️ CompletedThis study looked at how safe and effective two shingles vaccines (Zostavax and Shingrix) are in people with rheumatoid arthritis who are taking the drug abatacept. About 154 adults took part, and researchers measured their immune response and any side effects. The goal was to se…
Phase: PHASE2 • Sponsor: Kevin Winthrop • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:29 UTC
-
Cancer drug Imatinib's Long-Term safety tracked in ongoing patients
Disease control CompletedThis study looks at the long-term safety of imatinib, a daily pill for certain cancers like GIST and CML. It includes 250 patients who were already benefiting from imatinib in a previous Novartis trial and continue taking it. The main goal is to track side effects over time, with…
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Immune cells supercharged to fight cancer: early trial shows promise
Disease control CompletedThis early-phase trial tested whether giving patients their own natural killer (NK) cells, boosted by the drug bortezomib, is safe for treating advanced cancers like leukemia, lung, and pancreatic cancer. Thirty-five adults whose cancers had not responded to standard treatments r…
Phase: PHASE1 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Double-Barreled chemo attack on bile duct cancer shows promise
Disease control CompletedThis study tests a two-pronged chemotherapy approach for people with intrahepatic cholangiocarcinoma (a type of bile duct cancer) that cannot be removed by surgery. Participants receive chemotherapy directly to the liver through a surgically placed pump, plus standard chemotherap…
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New drug AZD9829 targets hard-to-treat blood cancers in early trial
Disease control CompletedThis study tests a new drug, AZD9829, in people with blood cancers that have come back or not responded to other treatments. The drug targets a protein called CD123 found on cancer cells. The main goals are to find a safe dose and check for side effects. About 56 adults will take…
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New hope for frail AML patients: stronger chemo regimens tested
Disease control CompletedThis study tests whether giving full-strength chemotherapy (either CPX-351 or a combination called CLAG-M) can help medically less-fit adults with acute myeloid leukemia live longer and achieve remission. About 60 participants will receive one of the two treatments. The goal is t…
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Your plate may fight psoriatic arthritis: diet study tests food as medicine
Disease control CompletedThis study investigates whether changing diet can reduce disease activity in people with psoriatic arthritis. Participants are randomly assigned to one of two diets: one focusing on which foods are eaten, and another limiting daily calorie intake. The trial lasts 24 weeks and inc…
Phase: NA • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New drug targets genetic weakness in Hard-to-Treat blood cancers
Disease control CompletedThis study tests a drug called FT-2102 (olutasidenib) in people with acute myeloid leukemia or myelodysplastic syndrome whose cancers have a specific IDH1 gene mutation. The drug is given alone or combined with standard chemotherapy drugs (azacitidine or cytarabine). The goal is …
Phase: PHASE1, PHASE2 • Sponsor: Forma Therapeutics, Inc. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Could a pill keep AML at bay? new study tests maintenance therapy after chemo
Disease control CompletedThis study looked at whether taking oral azacitidine (Onureg) as maintenance therapy can help older adults with acute myeloid leukemia (AML) stay in remission longer after treatment with CPX-351 chemotherapy. The study included 100 patients aged 65 and older who had achieved remi…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New drug hope for rare joint tumor patients who Can't have surgery
Disease control CompletedThis study tested a drug called pexidartinib (TURALIO) in 9 Japanese adults with tenosynovial giant cell tumor (TGCT), a rare, non-cancerous growth in the joints that causes pain and limits movement. The goal was to see if the drug is safe and can shrink tumors in people whose tu…
Phase: PHASE2 • Sponsor: Daiichi Sankyo Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Could a dementia drug shield kids' brains from radiation damage?
Disease control CompletedThis pilot study tested whether memantine, a drug used for dementia in adults, could help prevent memory and thinking problems in children receiving brain radiation for tumors like glioma or craniopharyngioma. 41 children aged 6-21 took either memantine or a placebo during radiat…
Phase: PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Cancer drug shows promise in slowing rare tumor growth
Disease control CompletedThis Phase 3 trial tested the drug sorafenib in 87 people with desmoid tumors, a rare type of growth that can be painful and invasive. The study compared sorafenib to a placebo to see if it could slow tumor progression. Sorafenib works by blocking proteins that help tumors grow. …
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New drug cocktail shows promise for Tough-to-Treat leukemia in seniors
Disease control CompletedThis study tested a chemotherapy drug called CPX-351 in 59 adults aged 60 to 75 with a high-risk form of acute myeloid leukemia (AML). The goal was to see how well it could put the cancer into remission. Participants received the drug through an IV, and some also had a stem cell …
Phase: PHASE2 • Sponsor: PETHEMA Foundation • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Rheumatoid arthritis drug baricitinib put to the test against TNF blockers in major safety trial
Disease control CompletedThis completed Phase 4 study compared the safety of baricitinib (a daily pill) to TNF inhibitors (injections) in over 2,600 adults with rheumatoid arthritis. The main goal was to see if baricitinib had a higher risk of blood clots. Participants had to be at least 60, have a histo…
Phase: PHASE4 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could a targeted drug keep AML in check?
Disease control CompletedThis phase III trial tests whether the drug tipifarnib can prevent acute myeloid leukemia (AML) from coming back in patients who are already in remission. Participants include adults over 60 in first remission, those in second or later remission, or those who achieved remission a…
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New lupus drug CUG252 passes first safety check in small trial
Disease control CompletedThis early-phase study tested the safety of a new drug, CUG252, in 40 adults with mild-to-moderate systemic lupus erythematosus (SLE). Participants received multiple doses of the drug or a placebo by injection. The main goal was to see if the drug is safe and tolerable, and to un…
Phase: PHASE1 • Sponsor: Cugene Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Joint injection shows promise for stopping repeat bleeds in hemophilia
Disease control CompletedThis study tested whether injecting bevacizumab (a drug that blocks blood vessel growth) into the joints of people with hemophilia can prevent repeated bleeding episodes. Eighteen participants with chronic synovitis (joint inflammation) received the injection. Researchers measure…
Phase: NA • Sponsor: Khyber Medical University Peshawar • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New hope for PMR patients: drug may replace long-term steroids
Disease control CompletedThis study tested two doses of secukinumab (a shot) combined with a steroid taper in 381 adults aged 50+ with polymyalgia rheumatica (PMR) who had recently relapsed. The goal was to see if secukinumab helps patients achieve and maintain remission without needing steroids long-ter…
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New combo therapy shows promise for rare sarcomas
Disease control CompletedThis study looked at adding the drug pazopanib to standard radiation or chemoradiation before surgery for patients with certain soft tissue sarcomas. The goal was to see if the combination is safe and helps shrink tumors more effectively. About 140 adults and children with newly …
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Short exercise program may cut heart risk in arthritis patients
Disease control CompletedThis completed study tested whether a 6-week cardiac rehabilitation program (aerobic and resistance exercises) could improve heart disease risk, blood pressure, and arthritis activity in 40 people with both rheumatoid arthritis and high blood pressure. Participants were randomly …
Phase: NA • Sponsor: Kayseri City Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Triple-Drug cocktail aims to boost remission in acute myeloid leukemia
Disease control CompletedThis phase 3 trial is testing whether a combination of three drugs—azacitidine, venetoclax, and ATRA—can safely and effectively treat adults newly diagnosed with acute myeloid leukemia (AML). The drugs work together to stop cancer cell growth by demethylating DNA, promoting cell …
Phase: PHASE3 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Experimental pill targets Hard-to-Treat blood cancers
Disease control CompletedThis study tested a daily pill called E7820 in 12 adults with relapsed or treatment-resistant acute myeloid leukemia, myelodysplastic syndromes, or chronic myelomonocytic leukemia. All participants had specific mutations in splicing factor genes. The goal was to see if the drug c…
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Experimental drug RAD001 tested for tough leukemias and lymphomas
Disease control CompletedThis study tested the drug RAD001 (everolimus) in 29 patients with relapsed or hard-to-treat blood cancers like leukemia, lymphoma, and myelofibrosis. The goal was to find the safest highest dose and see if it helps control the disease. It was a small early-phase trial at a singl…
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New PAH pill aims to delay worsening in large trial
Disease control CompletedThis study tested a new oral drug called ralinepag in 687 adults with pulmonary arterial hypertension (PAH), a serious lung condition that makes the heart work harder. Participants took ralinepag or a placebo on top of their usual PAH medications. The main goal was to see if rali…
Phase: PHASE3 • Sponsor: United Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New pill may keep soft tissue sarcoma in check after chemo
Disease control CompletedThis study tested whether taking anlotinib pills after initial chemotherapy can help keep advanced soft tissue sarcoma from growing. 49 adults with certain types of sarcoma took anlotinib daily. The goal was to see how long the cancer stayed stable and to check safety. Anlotinib …
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Immunotherapy boosts chemo against rare sarcomas?
Disease control CompletedThis study tested whether adding an immunotherapy drug called APX005M to standard chemotherapy (doxorubicin) could help shrink tumors in people with advanced soft tissue sarcoma. 27 adults with certain sarcoma types took part. The goal was to see if the combination was safe and w…
Phase: PHASE2 • Sponsor: Alexander Z. Wei, MD • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Experimental t cell therapy targets sarcoma in small early trial
Disease control CompletedThis early-phase trial tested a personalized cell therapy for people with advanced bone or soft tissue sarcoma that had stopped responding to standard treatment. The therapy uses the patient's own immune cells, modified to better recognize and attack cancer cells carrying a speci…
Phase: PHASE1 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New arthritis drug candidate SHR-3045 tested in healthy volunteers
Disease control CompletedThis Phase 1 study tested a single injection of SHR-3045 in 16 healthy adults to see if it is safe and how the body processes it. The drug is being developed as a potential treatment for rheumatoid arthritis, an autoimmune disease that causes joint pain and swelling. Because this…
Phase: PHASE1 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Real-World data on RA drug peficitinib: safety check in 3,000 patients
Disease control CompletedThis study looked at how safe and effective peficitinib is for people with rheumatoid arthritis (RA) in everyday medical practice. About 3,000 patients who were starting peficitinib for the first time took part. Researchers tracked side effects and measured disease activity using…
Sponsor: Astellas Pharma Inc • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Chemotherapy-Free combo aims to boost remission in younger AML patients
Disease control CompletedThis phase 2 trial is testing whether a combination of two drugs, venetoclax and azacitidine, can effectively treat adults aged 18 to 59 who have been newly diagnosed with acute myeloid leukemia (AML) and have not yet received any treatment. Participants take both drugs in cycles…
Phase: PHASE2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New drug combo aims to shrink fibroids in pregnant women
Disease control CompletedThis study tested a drug called SB-UF, which combines hormones and a plant extract, to see if it can shrink uterine fibroids in pregnant women. 66 women took the drug or a placebo throughout their pregnancy. The goal was to reduce fibroid size and help them disappear, which could…
Phase: PHASE4 • Sponsor: Trieu, Nguyen Thi, M.D. • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New drug could help patients with painful muscle disease ditch steroids
Disease control CompletedThis phase 3 trial tested whether abatacept, a drug that calms the immune system, can control polymyalgia rheumatica (a painful inflammatory condition) without the need for long-term steroids. Thirty-four adults with early disease received either abatacept or a placebo for 12 wee…
Phase: PHASE3 • Sponsor: University Hospital, Brest • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New hope for rare blood cancers: fedratinib shows promise in early trial
Disease control CompletedThis study tested a drug called fedratinib in 25 adults with rare blood cancers (MDS/MPN and CNL). The goal was to see if the drug could shrink the spleen and improve blood counts. While not a cure, the treatment aims to control the disease and reduce symptoms.
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New Stem-Free shoulder implant shows promise in european study
Disease control CompletedThis study followed 152 people who received the Sidus Stem-Free Shoulder implant for severe shoulder pain and disability due to arthritis or other joint diseases. The implant is designed to replace the shoulder joint without a long stem, potentially preserving more bone. Research…
Sponsor: Zimmer Biomet • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New hope for leukemia patients: asciminib shows promise in indian study
Disease control CompletedThis study looked at the safety and effectiveness of a drug called asciminib in 85 Indian adults with a specific type of leukemia (Ph+ CML-CP). Some participants had a genetic mutation (T315I) that can make treatment harder, while others had already tried two or more other drugs.…
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New combo therapy shows promise for hard-to-treat leukemia
Disease control CompletedThis early-phase trial tested whether adding the drug uproleselan to standard chemotherapy (cladribine and low-dose cytarabine) could help people with treated secondary acute myeloid leukemia (AML). Secondary AML is a type of leukemia that develops after treatment for another bon…
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New liposome combo shows promise for Tough-to-Treat leukemia
Disease control CompletedThis study tested a new formulation of two chemotherapy drugs (CPX-351) in 56 adults with newly diagnosed acute myeloid leukemia (AML) who were at high risk of not responding to standard treatment. The goal was to find the best dose and see how well it worked to stop cancer cells…
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New lupus drug shows promise in early safety trial
Disease control CompletedThis early-stage trial tested a drug called itolizumab (EQ001) in 52 adults with lupus, some of whom also had active kidney inflammation. The main goal was to check safety and find the right dose. Researchers also looked at how the drug behaves in the body and how it affects immu…
Phase: PHASE1 • Sponsor: Biocon Limited • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New drug cocktail shows promise against tough leukemia
Disease control CompletedThis study tested a combination of three drugs (decitabine, venetoclax, and ponatinib) in 20 adults with a rare, aggressive leukemia called Philadelphia chromosome-positive acute myeloid leukemia or chronic myelogenous leukemia in blast phase. The goal was to see if the drugs cou…
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New drug aims to cut steroid use in lung sarcoidosis
Disease control CompletedThis Phase 3 trial tested a drug called efzofitimod in 268 adults with pulmonary sarcoidosis, a condition that causes lung inflammation. Participants received either the drug or a placebo every 4 weeks for 48 weeks. The main goal was to see if the drug could help people safely re…
Phase: PHASE3 • Sponsor: aTyr Pharma, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Real-World lupus study reveals how new drug performs outside clinical trials
Disease control CompletedThis study looked at 152 adults with systemic lupus erythematosus (SLE) who started taking anifrolumab during its first year on the market in Spain. Researchers tracked their disease activity, flare-ups, and remission rates using standard medical records. The goal was to see how …
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New rheumatoid arthritis drug candidate passes first safety check in healthy volunteers
Disease control CompletedThis early-stage trial tested the safety of a new drug called SHR-3045 in 40 healthy adults. The study was randomized, double-blind, and placebo-controlled, meaning some participants got the drug and some got a dummy shot. The main goal was to see if the drug causes any side effe…
Phase: PHASE1 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New drug combo shrinks spleens in bone marrow cancer patients
Disease control CompletedThis study tested a new drug called pelabresib in people with certain blood cancers, including myelofibrosis and leukemia. In the first part, the drug was given alone to find the safest dose. In the second part, it was given with or without another drug (ruxolitinib) to see if it…
Phase: PHASE1, PHASE2 • Sponsor: Constellation Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Can a blood flow drug ease painful finger ulcers in scleroderma?
Disease control CompletedThis study tested the drug bosentan in 18 adults with systemic sclerosis who had reduced blood flow in their hands and a history of digital ulcers. The goal was to see if bosentan could improve hand blood flow measured by laser imaging and how blood flow relates to ulcer severity…
Phase: PHASE4 • Sponsor: Actelion • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Could a Gene-Targeting drug boost chemo for older leukemia patients?
Disease control CompletedThis study tested whether adding a drug called oblimersen to standard chemotherapy (daunorubicin and cytarabine) helps older adults (60+) with untreated acute myeloid leukemia live longer or achieve remission. About 500 participants were randomly assigned to receive chemo with or…
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New drug shows promise for Long-Term psoriatic arthritis control
Disease control CompletedThis study looked at the long-term safety and effectiveness of bimekizumab in adults with active psoriatic arthritis. Over 1,100 people who completed earlier studies received the drug and were monitored for side effects and disease symptoms. The goal was to see if bimekizumab rem…
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New pill for rare blood cancers shows promise in early trial
Disease control CompletedThis early-phase study tested a new drug called TQ05105 in 79 adults with certain blood cancers (myeloproliferative neoplasms). The main goals were to find the safest dose and understand side effects. The drug works by blocking a protein (JAK2) that can cause abnormal blood cell …
Phase: PHASE1 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
One cord blood unit may replace two in stem cell transplants for blood cancer
Disease control CompletedThis study tested a new way to treat blood cancers like leukemia in 16 adults who did not have a standard bone marrow donor. Doctors used a single unit of cord blood that was grown in a lab to increase the number of stem cells before transplant. The goal was to see if this method…
Phase: PHASE2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Immunotherapy combo shows promise for tough pituitary tumors
Disease control CompletedThis phase 2 trial tested two immunotherapy drugs, nivolumab and ipilimumab, in 10 patients with aggressive pituitary tumors that worsened after surgery and radiation. The goal was to see if the combination could shrink tumors or slow their growth. Researchers also monitored side…
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New pill shows promise in shrinking spleens for myelofibrosis patients
Disease control CompletedThis study tested a new drug called TQ05105 in 107 people with moderate to high-risk myelofibrosis, a rare bone marrow disorder that often causes an enlarged spleen. The goal was to see if TQ05105 could shrink the spleen better than the standard drug hydroxyurea. Participants too…
Phase: PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New combo therapy aims to improve survival in aggressive leukemia
Disease control CompletedThis large phase III trial tested whether adding the drugs bortezomib and sorafenib to standard chemotherapy helps people with newly diagnosed acute myeloid leukemia (AML) live longer without the cancer returning. Over 1,600 participants took part. The study focused on patients w…
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug shows promise in taming psoriatic arthritis flares
Disease control CompletedThis Phase 3 study tested guselkumab, a drug given by injection, in 741 adults with active psoriatic arthritis. The goal was to see if it reduces joint pain and swelling. Participants received either guselkumab or a placebo. The main measure was a 20% improvement in arthritis sym…
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Intense Pre-Transplant combo shows promise for tough leukemias
Disease control CompletedThis phase 2 trial tested a combination of intravenous busulfan, etoposide, and low-dose total-body irradiation before a donor stem cell or bone marrow transplant in 30 patients with advanced leukemia or myelodysplastic syndromes. The goal was to see how well this regimen control…
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Selective immune cell removal may tame transplant complications
Disease control CompletedThis study tested whether removing a specific type of immune cell (naïve T cells) from donor stem cell grafts could prevent graft-versus-host disease (GVHD) after a stem cell transplant for blood cancers. The trial enrolled 84 patients who received high- or medium-intensity chemo…
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could a gut bacteria booster ease rheumatoid arthritis?
Disease control CompletedThis pilot study tested whether a butyrate supplement, a type of short-chain fatty acid, could change the gut microbiome and immune responses in people with rheumatoid arthritis who didn't respond well to methotrexate. Twenty participants took the supplement for up to two months.…
Phase: NA • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can bosentan reverse lung artery thickening? small study investigates
Disease control CompletedThis study looked at whether bosentan (Tracleer) can reduce the thickness of lung artery walls in people with a type of high blood pressure in the lungs (pulmonary arterial hypertension, or PAH). Eleven adults with PAH took bosentan for 6 months. Researchers measured artery wall …
Phase: PHASE4 • Sponsor: Actelion • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New combo shows promise for High-Risk leukemia patients
Disease control CompletedThis study tested a new treatment for adults with a high-risk form of acute promyelocytic leukemia (APL). The experimental therapy combined arsenic trioxide, ATRA, and a low dose of idarubicin, aiming to improve survival and reduce side effects compared to the standard chemothera…
Phase: PHASE3 • Sponsor: Technische Universität Dresden • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can a biomarker predict who responds to a new AML combo?
Disease control CompletedThis phase 2 trial tested whether certain biomarkers in bone marrow can predict how well patients with high-risk acute myeloid leukemia (AML) respond to treatment with sirolimus plus standard chemotherapy (MEC). The study enrolled 39 adults with AML that was hard to treat or had …
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New pill aims to keep leukemia at bay after transplant
Disease control CompletedThis early-phase trial tested a drug called ONC-201 in 20 people with high-risk acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) who had recently received a stem cell transplant. Participants took the drug by mouth once a week for a year to see if it was safe and co…
Phase: PHASE1 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New lupus drug shows early promise in small trial
Disease control CompletedThis early-phase trial tested an experimental drug called DS-7011a in 26 adults with systemic lupus erythematosus (SLE), a chronic autoimmune disease. The study aimed to check the drug's safety and how the body processes it, not yet to prove it works. Participants received either…
Phase: PHASE1, PHASE2 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New drug combo may make cord blood transplants safer for blood cancer patients
Disease control CompletedThis study tested whether adding the drug tocilizumab to standard care could reduce the risk of graft-versus-host disease (GVHD) after a cord blood transplant in adults with blood cancers. GVHD is a serious complication where donor cells attack the patient's body. Tocilizumab blo…
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New drug shows promise for rare muscle disease
Disease control CompletedThis study tested an experimental drug called daxdilimab in 12 adults with dermatomyositis or anti-synthetase myositis that wasn't well controlled by standard treatments. The goal was to see if the drug could reduce disease activity and skin symptoms, and help lower steroid use o…
Phase: PHASE2 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New chemo cocktail aims to beat back leukemia relapse
Disease control CompletedThis phase 2 trial tests whether a combination of clofarabine and intermediate-dose cytarabine (CLARA) works better than high-dose cytarabine (HDAC) alone as consolidation therapy for younger adults (18-60) with newly diagnosed acute myeloid leukemia (AML). After initial remissio…
Phase: PHASE2 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Text reminders and calls help veterans take lifesaving pills
Disease control CompletedThis study tested a program to help veterans with heart disease or rheumatic conditions take their medications as prescribed. Over 5,000 participants received reminders via text or phone calls, with extra support if needed. The goal was to improve medication adherence and reduce …
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Can a second-line drug help CML patients stay cancer-free without daily pills?
Disease control CompletedThis study looked at 31 adults with chronic myeloid leukemia (CML) whose cancer came back after they stopped taking imatinib. They were given nilotinib, a more powerful targeted therapy, to see if it could make their cancer undetectable again and allow them to stop treatment once…
Phase: PHASE2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New lupus drug candidate BMS-986326 enters early human testing
Disease control CompletedThis early-phase study tested a new drug called BMS-986326 in 45 adults with different forms of lupus, including skin and systemic lupus. The main goal was to check safety and how the body processes the drug, not yet to see if it works. Participants received either the drug or a …
Phase: PHASE1 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Can a diabetes drug tame obesity caused by brain tumor treatment?
Disease control CompletedThis study tested whether exenatide, a diabetes drug, plus lifestyle changes helps adults with severe weight gain after treatment for a rare brain tumor (craniopharyngioma). 42 adults aged 18-75 took either exenatide or a placebo for 6 months. The main goal was to see if they los…
Phase: PHASE3 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Real-world filgotinib study tracks arthritis control over 2 years
Disease control CompletedThis study followed 155 French adults with moderate-to-severe rheumatoid arthritis who were prescribed filgotinib (Jyseleca) for the first time. Over two years, researchers measured how many patients stayed on the drug and how well it controlled their disease activity. The goal w…
Sponsor: Alfasigma S.p.A. • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New hope for stroke survivors with rare clotting disorder: rivaroxaban vs warfarin
Disease control CompletedThis study tested whether the drug rivaroxaban works as well as warfarin to prevent further brain damage in people who have had a stroke due to antiphospholipid syndrome (APS), a condition that causes abnormal blood clotting. About 40 participants took either rivaroxaban or warfa…
Phase: PHASE2 • Sponsor: University College, London • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New pill could ease rheumatoid arthritis pain
Disease control CompletedThis study tested an experimental oral drug called LY3871801 in 164 adults with moderately-to-severe rheumatoid arthritis. The goal was to see if it reduces joint swelling and pain better than a placebo. The trial is complete, and results will help decide if further testing is wa…
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New hope for tough MDS: drug trio targets resistant cancer cells
Disease control CompletedThis study tested a three-drug combination (navitoclax, venetoclax, and decitabine) in 6 adults with high-risk myelodysplastic syndrome (MDS) that came back or didn't respond to standard therapy. The goal was to find the safest dose and see if the combo could shrink or control th…
Phase: PHASE1 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Zapping tumors with precision radiation may help control limited metastatic breast cancer
Disease control CompletedThis study looked at whether adding focused radiation (SBRT) or surgery to standard treatments like chemo or hormone therapy helps people with breast cancer that has spread to just one or two places. 129 participants were randomly assigned to get standard care alone or standard c…
Phase: PHASE2, PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New hope for kids with tough leukemia: experimental combo tested
Disease control CompletedThis early-phase study tested a combination of three chemotherapy drugs (CPX-351 and gemtuzumab ozogamicin) in children whose acute myeloid leukemia (AML) had come back or didn't respond to standard treatment. The main goals were to find the best dose and check for side effects. …
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Daily painkillers may shield spines in arthritis patients on biologics
Disease control CompletedThis study looked at whether taking NSAIDs every day, instead of only when needed, can prevent spine damage in people with ankylosing spondylitis who are also receiving anti-TNF therapy. 188 adults participated in this Phase 3 trial. The goal was to see if continuous NSAID use re…
Phase: PHASE3 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Leukemia drug holiday: study finds many can stop imatinib without relapse
Disease control CompletedThis study looked at 220 adults with chronic myeloid leukemia who had been in deep remission for at least two years while taking imatinib. Researchers wanted to see if stopping the drug would cause the cancer to come back. They found that many patients stayed in remission after s…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New drug shows promise for lupus in asian patients
Disease control CompletedThis study tested a drug called anifrolumab in 277 Asian adults with active lupus. The goal was to see if it could better control the disease compared to a placebo, when added to standard treatments. Participants received the drug or placebo through an IV, and researchers measure…
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Experimental combo targets Hard-to-Treat blood cancers
Disease control CompletedThis early-phase study tested a new drug called TGR-1202 combined with the standard drug ruxolitinib in 60 people with myelofibrosis or polycythemia vera. The goal was to see if the combination is safe and tolerable. Participants either had not responded well to ruxolitinib alone…
Phase: PHASE1 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Lupus drug benlysta proves safe and effective in large Real-World trial
Disease control CompletedThis study looked at the long-term safety and effectiveness of Benlysta, a medication for systemic lupus erythematosus (SLE), in over 1,500 patients in everyday medical practice. Researchers tracked participants for 52 weeks, monitoring side effects, disease activity, and quality…
Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New hope for AML patients: drug combo targets leukemia cells
Disease control CompletedThis study tested a new drug called S65487, which blocks a protein that helps leukemia cells survive, combined with the standard drug azacitidine. The trial included 57 adults with untreated acute myeloid leukemia who were not healthy enough for intensive chemotherapy. Researcher…
Phase: PHASE1, PHASE2 • Sponsor: Institut de Recherches Internationales Servier • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New lupus pill shows promise in Mid-Stage trial
Disease control CompletedThis study tested an oral medication called GLPG3667 in 186 adults with active systemic lupus erythematosus (SLE). Participants took the drug or a placebo once daily for 48 weeks. The goal was to see if the drug could reduce lupus disease activity and improve symptoms, while moni…
Phase: PHASE2 • Sponsor: Lakefront Biotherapeutics NV • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New hope for lupus patients: two experimental drugs show promise in reducing disease activity
Disease control CompletedThis study tested two experimental drugs, VAY736 and CFZ533, in 107 adults with systemic lupus erythematosus (SLE). The goal was to see if these drugs could reduce lupus symptoms and allow patients to lower their steroid use. Participants received either one of the drugs or a pla…
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Promising combo tackles FLT3 leukemia in early trial
Disease control CompletedThis early-phase study tested whether adding two targeted drugs, gemtuzumab ozogamicin and midostaurin, to standard chemotherapy is safe for people with a newly diagnosed, aggressive form of acute myeloid leukemia (AML) that has a FLT3 mutation. The trial enrolled 21 adults and a…
Phase: PHASE1 • Sponsor: Uma Borate • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New birth control pill aims to help women with painful conditions
Disease control CompletedThis study tested whether a daily combination pill (relugolix, estradiol, and norethindrone acetate) can prevent pregnancy in women aged 18 to 50 who have uterine fibroids or endometriosis. Over 1,100 women took the pill for up to a year, and researchers counted how many became p…
Phase: PHASE3 • Sponsor: Sumitomo Pharma Switzerland GmbH • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Cancer drug shows promise for rare skin disease
Disease control CompletedThis study tested whether imatinib, a drug used for certain cancers, can reduce skin hardening in people with severe scleroderma. 28 adults received either imatinib or a placebo for 6 months. The main goal was to see if the drug improved skin thickness and quality of life.
Phase: PHASE2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New pill could ease rare muscle disease
Disease control CompletedThis study tested an oral drug called GLPG3667 (Cadefrecitinib) in 40 adults with dermatomyositis, a rare disease causing muscle weakness and skin rash. Participants took the drug or a placebo daily for 24 weeks to see if it improves symptoms. The trial is complete, and results w…
Phase: PHASE2 • Sponsor: Lakefront Biotherapeutics NV • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New combo therapy targets both joint pain and obesity in PsA patients
Disease control CompletedThis study tested whether adding a weight-loss drug (tirzepatide) to a standard arthritis drug (ixekizumab) helps people with psoriatic arthritis who are overweight or obese. 279 adults with active psoriatic arthritis and a BMI of 27 or higher took part. The goal was to see if th…
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Immunotherapy combo shows promise for Post-Transplant leukemia relapse
Disease control CompletedThis phase 1 trial tested two immunotherapy drugs, nivolumab and ipilimumab, in 29 patients whose acute myeloid leukemia or myelodysplastic syndrome came back or did not respond after a donor stem cell transplant. The goal was to find the safest dose and see if the drugs could he…
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Can a viagra drug heal scleroderma finger sores?
Disease control CompletedThis study tested whether sildenafil (the drug in Viagra) can help heal painful finger ulcers in people with scleroderma, a disease that damages blood vessels. 84 participants took either sildenafil or a placebo three times daily for 90 days. The main goal was to see if the ulcer…
Phase: PHASE3 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New hope for older AML patients: triple drug combo aims to control disease and prevent relapse
Disease control CompletedThis study tested a combination of three drugs (low-dose cytarabine or azacitidine, plus venetoclax and quizartinib) in 113 adults aged 60 and older with newly diagnosed acute myeloid leukemia (AML) who were not eligible for standard chemotherapy. The goal was to quickly control …
Phase: PHASE1, PHASE2 • Sponsor: PETHEMA Foundation • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Robotic knee surgery put to the test in 252-Patient study
Disease control CompletedThis study looked at whether using a robotic system (ROSA) during knee replacement surgery leads to more accurate implant placement compared to traditional methods. It included 252 adults with knee pain, arthritis, or deformities who were already scheduled for knee replacement. R…
Phase: NA • Sponsor: Zimmer Biomet • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New hope for arthritis sufferers: filgotinib shows promise in korean trial
Disease control CompletedThis study tested the drug filgotinib (Jyseleca) in 118 Korean adults with rheumatoid arthritis. The goal was to see how many patients experienced at least a 20% improvement in symptoms after 12 weeks of treatment. The trial is complete, and results will help determine if filgoti…
Phase: PHASE4 • Sponsor: Eisai Korea Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New hope for kids with lupus: belimumab shows promise in chinese trial
Disease control CompletedThis study looked at whether adding belimumab to standard treatment is safe and effective for Chinese children aged 5 to 17 with active lupus. 67 participants received belimumab plus their usual therapy. The main goal was to check for serious side effects and see if lupus disease…
Phase: PHASE4 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New triple-drug combo shows promise for hard-to-treat leukemia patients
Disease control CompletedThis early-phase study tested a new drug called siremadlin added to two existing drugs (venetoclax and azacitidine) for adults with acute myeloid leukemia (AML) who are too frail for standard chemotherapy. The study included 14 people whose cancer did not respond well to initial …
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New pill could reduce Blood-Letting for rare blood cancer patients
Disease control CompletedThis phase 2 study tested an oral drug called bomedemstat in 20 adults with polycythemia vera, a rare blood cancer that causes too many red blood cells. The main goal was to see if the drug could safely lower red blood cell levels enough to avoid routine blood removal (phlebotomy…
Phase: PHASE2 • Sponsor: Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA) • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New pill shows promise for rare blood disorder
Disease control CompletedThis study tested an experimental pill called Bomedemstat in 73 people with essential thrombocythemia, a rare blood condition causing too many platelets. Participants had already tried at least one standard treatment without success. The main goals were to check safety and see if…
Phase: PHASE2 • Sponsor: Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA) • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Pill may replace shots for blood cancer patients, study finds
Disease control CompletedThis study tested whether an oral medication (CC-486) could help elderly patients with a serious blood disorder called myelodysplastic syndrome (MDS) maintain their improvement after initial injectable treatment. Eleven patients who had responded to injectable azacitidine switche…
Phase: PHASE2 • Sponsor: University of Florence • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New hope for tough blood cancers? early trial tests LYT-200
Disease control CompletedThis early-stage study tested a new drug called LYT-200 in 101 adults whose acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS) had come back or stopped responding to treatment. The main goals were to check the drug's safety and find the right dose. While not…
Phase: PHASE1 • Sponsor: PureTech • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Experimental combo targets stubborn leukemia in tiny trial
Disease control CompletedThis early-phase trial tested a combination of two drugs, enasidenib and cobimetinib, in just 3 patients with a specific form of acute myeloid leukemia (AML) that had come back or didn't respond to treatment. The goal was to see if the combination was safe and to find the best do…
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Stem cells and oxygen therapy may save hips from collapse
Disease control CompletedThis study tested a triple therapy—surgery, stem cells, and hyperbaric oxygen—in 24 patients with early-stage osteonecrosis (bone death) of the hip. After two years, patients reported better hip function and fewer needed a hip replacement. The approach aims to stop the bone from …
Sponsor: Ankara City Hospital Bilkent • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Antidepressant shows promise for arthritis relief in new trial
Disease control CompletedThis phase 3 trial tested whether adding paroxetine, an antidepressant, to standard methotrexate therapy can better control rheumatoid arthritis. 100 adults with active RA took part. The main goal was to see if the combination lowers disease activity scores more than methotrexate…
Phase: PHASE3 • Sponsor: Mostafa Bahaa • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New pill shows promise against tough blood cancers
Disease control CompletedThis early-stage trial tested an oral drug called NTX-301 in 22 adults with certain blood cancers (MDS, AML, or CMML) that had not responded to prior treatments. The main goal was to check safety and find the right dose. Researchers also looked for signs that the drug might help …
Phase: PHASE1 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Can a blood vessel drug save kidneys in scleroderma crisis?
Disease control CompletedThis study tested a drug called bosentan in 16 adults with scleroderma who had a serious kidney complication called scleroderma renal crisis. The goal was to see if bosentan could help protect kidney function and improve survival over 6 months to a year. The drug works by blockin…
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Stem cell transplant study seeks best way to prevent immune attack
Disease control CompletedThis study tested different drug combinations to prevent graft-versus-host disease (GVHD) in 174 people with blood cancers receiving stem cells from an unrelated donor. GVHD is a serious side effect where donor cells attack the patient's body. The goal was to find which drug regi…
Phase: PHASE3 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Skyrizi under the microscope: Real-World safety data on over 2,300 patients
Disease control CompletedThis study tracked over 2,300 adults in Korea who were prescribed Skyrizi (risankizumab) for moderate to severe plaque psoriasis or psoriatic arthritis. Researchers monitored side effects and symptom changes for 52 weeks during routine doctor visits. The goal was to confirm the d…
Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Custom 3D-Printed plates and rib grafts show promise for jaw reconstruction
Disease control CompletedThis study tested a new way to rebuild the lower jaw after removing benign tumors. Surgeons used virtual 3D planning to create custom-made plates and combined them with a piece of the patient's own rib bone. Thirty people took part, and the team checked how well the wounds healed…
Phase: NA • Sponsor: Alexandria University • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Supercharged immune cells take on relapsed leukemia in new trial
Disease control CompletedThis study tested a new approach for children and adults whose acute myeloid leukemia (AML) came back after a stem cell transplant. Researchers gave patients a special type of immune cell called cytokine-induced memory-like natural killer (CIML NK) cells, along with donor immune …
Phase: PHASE1, PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New combo pill shows promise for stubborn leukemia
Disease control CompletedThis phase 2 trial tested whether adding asciminib to the standard drug imatinib helps people with chronic myeloid leukemia (CML) achieve deeper remission. 104 adults who had been on imatinib for at least a year without reaching very low cancer levels were randomly assigned to ad…
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Umbilical cord stem cells tested for rare lung condition
Disease control CompletedThis study tested a single intravenous infusion of stem cells from donated umbilical cord tissue in one person with severe scleroderma that had caused lung scarring and high blood pressure in the lungs. The goal was to see if the treatment could improve lung function, exercise ab…
Phase: PHASE1, PHASE2 • Sponsor: Fundación Neumologica Colombiana • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Bone filler injection in hip shows promise for pain relief
Disease control CompletedThis study followed 77 people who had a procedure called Subchondroplasty for hip bone defects. Doctors injected a calcium phosphate bone filler into the damaged area. The goal was to see if it improved pain, movement, and daily activities over two years. Results were measured us…
Sponsor: Zimmer Biomet • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Promising drug combo targets tough leukemia in early trial
Disease control CompletedThis early-phase study tested a two-drug combination (pevonedistat plus decitabine) in 12 people with high-risk acute myeloid leukemia (AML), including those who had relapsed or couldn't tolerate standard chemo. The main goal was to find the safest dose and identify side effects.…
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New knee prosthesis helps bone cancer patients walk again
Disease control CompletedThis study looked at how well a special knee replacement (MUTARS) works after removing bone cancer. Nine patients were checked to see if they could lock their new knee and walk actively. The goal was to understand if the prosthesis helps with daily movement and walking.
Phase: NA • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug combo shows promise for rare childhood muscle disease
Disease control CompletedThis study tested the drug baricitinib, given with steroids, in 16 children aged 3-18 with newly diagnosed juvenile dermatomyositis, a rare disease causing muscle weakness and skin rashes. The goal was to see if baricitinib works better than the standard treatment (methotrexate p…
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Hope for RVCL: experimental drug tested in tiny trial
Disease control CompletedThis phase 2 trial tested the drug crizanlizumab in 18 people with RVCL, a rare and fatal genetic condition that damages small blood vessels in the brain and eyes. There is currently no treatment for RVCL. The study measured changes in brain lesions on MRI scans to see if the dru…
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can a lupus drug shield organs from Long-Term harm?
Disease control CompletedThis study looked at whether the drug anifrolumab, when added to standard lupus treatments, can reduce long-term organ damage compared to standard care alone. Researchers analyzed data from 561 adults with active lupus, comparing those who took anifrolumab in earlier trials to si…
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New arthritis drug shows promise in major trial
Disease control CompletedThis study tested an injectable drug called CT-P13 in 192 adults with moderate-to-severe rheumatoid arthritis. The goal was to see if it reduces joint pain and swelling better than a placebo. Participants received either the drug or a dummy shot, and researchers measured improvem…
Phase: PHASE3 • Sponsor: Celltrion • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for kids with lupus: drug trial shows promise
Disease control CompletedThis study tested the drug belimumab in children aged 5 to 17 with active lupus. Participants received either belimumab or a placebo alongside their usual treatments. The goal was to see if belimumab could safely reduce lupus disease activity over 52 weeks.
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
Gum gel shows promise in small study
Disease control CompletedThis study looked at whether a special gel could help treat gum disease. Twelve adults with moderate gum disease received standard deep cleaning plus the gel. They also used the gel and a special toothpaste at home. After 8 weeks, their gum pockets and bleeding improved. The stud…
Phase: NA • Sponsor: University of Roma La Sapienza • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
Old drug, new hope: enasidenib may ease anemia in blood cancer patients
Disease control CompletedThis early-phase trial tested the drug enasidenib in 17 people with low-risk myelodysplastic syndrome or a related leukemia who had anemia and did not have a specific gene mutation. The goal was to see if the drug could safely improve red blood cell counts and reduce the need for…
Phase: PHASE1, PHASE2 • Sponsor: Tian Yi Zhang • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New gel therapy aims to calm brain inflammation without harsh steroid side effects
Disease control CompletedThis study tested whether H.P. Acthar Gel can improve symptoms and quality of life in people with CNS sarcoidosis, a rare condition where inflammation affects the brain and spinal cord. Four adults with the disease received the gel to see if it could control disease activity and …
Phase: PHASE4 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New psoriasis drug shows promise in major trial
Disease control CompletedThis study tested a new drug called bimekizumab in 567 adults with moderate to severe plaque psoriasis. Participants received either bimekizumab, a placebo, or another active drug. The main goal was to see how well bimekizumab cleared skin lesions after 16 weeks. Results showed s…
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New Two-Step transplant shows promise for blood cancer patients
Disease control CompletedThis study tested a two-step stem cell transplant for people with blood cancers like leukemia and lymphoma. First, patients received low-dose chemotherapy and radiation to prepare their bodies. Then, they got donor stem cells followed by drugs to prevent the donor cells from atta…
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New drug bimekizumab shows promise in clearing psoriasis in phase 3 trial
Disease control CompletedThis phase 3 study tested bimekizumab, a drug given by injection, against a placebo in 435 adults with moderate to severe plaque psoriasis. The main goal was to see how many people achieved at least 90% skin clearing after 16 weeks. The trial also looked at complete clearing and …
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Ultrasound may spot arthritis Flare-Ups before symptoms start
Disease control CompletedThis study tested whether ultrasound could detect signs of rheumatoid arthritis (RA) relapse before symptoms appear in patients treated with rituximab. Thirty adults with RA who had not responded to at least one TNF-blocking drug were included. Researchers used ultrasound to meas…
Phase: PHASE4 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Bladder bacteria transplant shows promise for painful condition
Disease control CompletedThis phase 1 trial tested a new treatment called urinary microbiota transplantation (UMT) for people with cystitis glandularis, a chronic bladder condition often linked to pelvic lipomatosis. The treatment involves placing processed donor urine bacteria into the bladder. After on…
Phase: PHASE1 • Sponsor: Peking University First Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New drug NTR-1011 tested for autoimmune diseases
Disease control CompletedThis early-stage trial tested the safety of a new drug called NTR-1011 in 36 healthy adults and people with lupus or rheumatoid arthritis. The study aimed to find a safe dose and see how the drug behaves in the body. It is a first step toward possibly developing a new treatment f…
Phase: PHASE1 • Sponsor: Neutrolis • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New drug combo shows promise for Tough-to-Treat psoriatic arthritis
Disease control CompletedThis study tested whether combining two drugs (guselkumab and golimumab) works better than one drug alone for people with active psoriatic arthritis who didn't get enough relief from previous TNF-alpha blockers. 91 adults took part. The goal was to see if the combo could help mor…
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Arthritis patients may swap IV infusions for convenient at-home shots
Disease control CompletedThis study tested whether people with rheumatoid arthritis, psoriatic arthritis, or spine arthritis could safely switch from receiving infliximab through an IV infusion at a clinic to giving themselves a simple shot under the skin at home. 22 adults who were already stable on IV …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New drug shows promise in leukemia battle
Disease control CompletedThis study tested a new drug, crenolanib, against the standard drug midostaurin in adults with a specific genetic type of acute myeloid leukemia (FLT3-mutated AML). All 214 participants received standard chemotherapy and, if eligible, a bone marrow transplant, plus one of the two…
Phase: PHASE3 • Sponsor: Arog Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New drug combo aims to prevent leukemia return after remission
Disease control CompletedThis study tested whether a combination of two drugs, venetoclax and azacitidine, can help adults with acute myeloid leukemia (AML) stay in remission after initial chemotherapy. The goal was to find the right dose and see if it safely delays the cancer from coming back. The study…
Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New hope for elderly leukemia patients: drug combo shows promise
Disease control CompletedThis study tested a combination of two drugs, azacitidine and venetoclax, in 42 elderly patients (age 60+) with newly diagnosed acute myeloid leukemia (AML) who could not have standard chemotherapy. The treatment was given as an initial 'induction' phase, followed by a 'maintenan…
Phase: PHASE2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Promising combo targets Leukemia's genetic weakness
Disease control CompletedThis study tested whether adding the drug crenolanib to standard chemotherapy helps adults up to age 75 with a hard-to-treat form of acute myeloid leukemia (AML) that has a specific genetic change (FLT3 mutation). Participants received either crenolanib or a placebo alongside che…
Phase: PHASE3 • Sponsor: Arog Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New procedure for foot stress fractures shows promise in 148-Patient study
Disease control CompletedThis study followed 148 people who had a procedure called Subchondroplasty® for stress fractures or bone defects in the foot or ankle. Researchers tracked pain, function, and satisfaction for up to 24 months after surgery. The goal was to see how well the procedure helps patients…
Sponsor: Zimmer Biomet • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Can a natural compound ease rheumatoid arthritis?
Disease control CompletedThis study tested a compound called 2-HOBA in 32 adults with rheumatoid arthritis. Participants took either 2-HOBA or a placebo three times a day for 4 weeks. The goal was to see if 2-HOBA is safe and reduces markers of inflammation. This early research helps plan larger future s…
Phase: PHASE2 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New drug combo offers hope for myelofibrosis patients who failed standard therapy
Disease control CompletedThis study tested a combination of two drugs, fedratinib and nivolumab, in 30 adults with myelofibrosis whose disease no longer responded well to standard JAK-inhibitor treatment. The goal was to see if the combination could shrink the spleen, improve symptoms, or reduce the need…
Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Personalized plans boost survival odds for older stem cell patients
Disease control CompletedThis study tested a personalized geriatric optimization plan (GO!) in 30 adults aged 60 and older who were getting a donor stem cell transplant for blood cancers or bone marrow failure. The plan included tailored advice on diet, sleep, activity, and medications to improve physica…
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Dietary change may curb recurrent c. diff in cancer patients
Disease control CompletedThis study tested whether eating less fat and more fiber can reduce the chance of a repeat Clostridioides difficile infection in cancer patients. Eight participants with leukemia, lymphoma, or other cancers followed a specific diet. Researchers tracked diarrhea and measured C. di…
Phase: NA • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Could a probiotic help kids with arthritis?
Disease control CompletedThis study tested whether taking a probiotic called VSL#3, alongside standard treatment, can reduce disease activity in children with juvenile idiopathic arthritis (JIA). Fifty-one children aged 1 to 7 with specific types of JIA took either the probiotic or a placebo. Researchers…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New targeted therapy shows promise for Tough-to-Treat leukemia
Disease control CompletedThis study tested a drug called GO-203-2C, which targets a protein (MUC1) found on cancer cells while sparing healthy cells. It was given alone or with another drug (decitabine) to 33 adults with acute myeloid leukemia that had returned or not responded to treatment. The main goa…
Phase: PHASE1, PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Can a second drug stop the body from rejecting arthritis treatment?
Disease control CompletedThis study looked at whether adding methotrexate to adalimumab (a biologic drug) reduces the chance that the body makes antibodies against adalimumab in people with ankylosing spondylitis. About 110 adults with active disease who did not respond well to NSAIDs took part. The goal…
Phase: PHASE4 • Sponsor: University Hospital, Tours • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Engineered immune cells take on tough blood cancers in early trial
Disease control CompletedThis study tested a new treatment called CTX131 for adults with certain blood cancers (T-cell lymphoma, B-cell lymphoma, or acute myeloid leukemia) that had returned or stopped responding to standard therapy. CTX131 uses a patient's own immune cells, modified with CRISPR gene edi…
Phase: PHASE1, PHASE2 • Sponsor: CRISPR Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Can CML patients pause treatment? new study explores Drug-Free remission
Disease control CompletedThis study looked at 124 adults with chronic myeloid leukemia (CML) who had been on the drug nilotinib for at least 3 years and had very low levels of cancer. First, researchers tested if lowering the nilotinib dose by half for a year could help patients stop treatment entirely. …
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New drug cocktail aims to tame deadly transplant complication
Disease control CompletedThis study tested whether adding pacritinib to standard immune-suppressing drugs (sirolimus and tacrolimus) could prevent graft-versus-host disease (GVHD) in 40 patients receiving stem cell transplants for blood cancers. GVHD occurs when donor immune cells attack the recipient's …
Phase: PHASE1, PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Double-Drug attack shows promise for tough head and neck cancers
Disease control CompletedThis study tested whether combining two FDA-approved cancer drugs, cetuximab and nivolumab, could help people with advanced head and neck cancer that has returned or spread. A total of 95 participants received the drug combination to find the best dose and see if it improves surv…
Phase: PHASE1, PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New device may straighten bent fingers without surgery
Disease control CompletedThis study tested a device called MiniFlo that slowly stretches bent fingers back into place in people with advanced Dupuytren's disease. 18 adults with stage III-IV disease used the device. Researchers measured how much finger straightening improved and checked for pain or side …
Phase: NA • Sponsor: Azienda Ospedaliera Universitaria Integrata Verona • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New biologic shows promise for rare inflammatory disease in japan
Disease control CompletedThis study tested canakinumab, an anti-inflammatory biologic, in 14 Japanese adults with Adult-Onset Still's Disease (AOSD), a rare condition causing fevers and joint pain. Participants received injections every 4 weeks for at least 48 weeks. The goal was to see if the drug could…
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New shoulder implant shows promise in early study
Disease control CompletedThis study tested a new shoulder implant called the Catalyst CSR System in 87 people with shoulder arthritis or bone damage. The implant is designed to preserve more natural bone than traditional replacements. Researchers measured pain, movement, and implant safety over two years…
Phase: NA • Sponsor: Catalyst OrthoScience • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New drug combo aims to tame deadly transplant complication
Disease control CompletedThis phase II trial tested whether adding the drug itacitinib to standard medications (tacrolimus and sirolimus) can better prevent graft-versus-host disease (GVHD) in 59 patients with blood cancers receiving donor stem cell transplants. GVHD occurs when donor immune cells attack…
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New biologic KD6005 tested in first human trial for rheumatoid arthritis
Disease control CompletedThis early-stage trial tested a new biologic drug called KD6005 in 73 people: first in healthy volunteers, then in patients with rheumatoid arthritis. The main goal was to check safety and how the body processes the drug. It is too soon to know if KD6005 works, but this study is …
Phase: PHASE1 • Sponsor: Shanghai Kanda Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New radiation approach aims to tame pituitary tumors with fewer side effects
Disease control CompletedThis study tested a new way of delivering radiation for people with non-secreting pituitary adenomas that came back or remained after surgery. Instead of a single high dose, the radiation was given in five smaller daily doses. The goal was to see if this approach could control tu…
Phase: NA • Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Could a Pre-Transplant drug boost survival in myelofibrosis?
Disease control CompletedThis phase 2 trial looked at whether giving a JAK inhibitor (ruxolitinib) before a donor stem cell transplant helps people with myelofibrosis. The study enrolled 61 patients with primary or secondary myelofibrosis. The goal was to see if this approach improves survival and reduce…
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New IV treatment explored for painful inflammatory conditions
Disease control CompletedThis study looked at how an intravenous (IV) form of secukinumab is processed by the body and whether it is safe for adults with giant cell arteritis (GCA) or polymyalgia rheumatica (PMR). These conditions cause inflammation in blood vessels or muscles, leading to pain and stiffn…
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Drug cocktail shows promise against rare bone marrow cancers
Disease control CompletedThis study tested a combination of two drugs, ruxolitinib and azacytidine, in 121 people with myelofibrosis or related blood cancers. The goal was to see if the combo could shrink tumors or improve blood counts. While the treatment aims to control the disease, it is not a cure, a…
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Could a Heart-Healthy diet tame rheumatoid arthritis?
Disease control CompletedThis completed study looked at whether the DASH diet, known for lowering blood pressure, can help people with rheumatoid arthritis. Forty-nine adults with active disease followed a personalized DASH diet for 12 weeks. Researchers measured changes in disease activity, pain, and in…
Phase: NA • Sponsor: Istanbul Health and Technology University • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New penile implant study shows promise for Men's confidence
Disease control CompletedThis study tested a silicone block placed under the skin of the penis to improve its size, shape, and appearance. It included 40 men who were unhappy with their penile girth or length. The main goal was to check safety and measure changes in size and patient satisfaction.
Sponsor: International Medical Devices, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New drug XKH004 shows promise in phase 3 trial for back pain from ankylosing spondylitis
Disease control CompletedThis Phase 3 trial tested a new drug called XKH004 in 323 adults with moderate-to-severe active ankylosing spondylitis, a type of arthritis that causes back pain and stiffness. The drug works by blocking two inflammatory proteins, IL-17A and IL-17F. Participants received either X…
Phase: PHASE3 • Sponsor: Zhejiang Kanova Biopharmaceutical Co., LTD • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Expanded cord blood transplant shows early promise for young cancer patients
Disease control CompletedThis study tested a new method of cord blood transplantation in 13 children and young adults with high-risk myeloid cancers. The approach uses a molecule called UM171 to grow more stem cells from a single cord blood unit, aiming to speed up recovery and reduce complications. Earl…
Phase: PHASE1, PHASE2 • Sponsor: ExCellThera inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New pill combo aims to improve AML treatment in Non-FLT3 patients
Disease control CompletedThis phase 2 trial tested whether adding the targeted drug quizartinib to standard chemotherapy helps adults with newly diagnosed acute myeloid leukemia (AML) that does not have a FLT3 mutation. 273 patients were randomly assigned to receive either quizartinib or a placebo alongs…
Phase: PHASE2 • Sponsor: PETHEMA Foundation • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New radiation combo aims to boost stem cell transplant success in tough leukemia cases
Disease control CompletedThis study tested a new way to prepare patients with relapsed or hard-to-treat acute leukemia for a donor stem cell transplant. It combined a precise form of radiation therapy (IMRT) with two chemotherapy drugs (etoposide and cyclophosphamide) before the transplant. The goal was …
Phase: PHASE1, PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Stem cell transplant shows promise for scleroderma patients
Disease control CompletedThis study compared two treatment strategies for people with early, severe scleroderma: a stem cell transplant using their own cells versus standard immunosuppressive drugs. The trial enrolled 60 adults with diffuse cutaneous systemic sclerosis. The goal was to see which approach…
Phase: PHASE4 • Sponsor: UMC Utrecht • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New study: can upadacitinib ease back pain in axial spondylarthritis?
Disease control CompletedThis study looked at how well upadacitinib, an anti-inflammatory pill, controls pain in people with axial spondylarthritis (axSpA), a condition causing chronic back pain. Over 700 adults from 19 countries took the drug as prescribed by their doctors and were followed for 12 month…
Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Arthritis drug tofacitinib tested for Long-Term safety in kids
Disease control CompletedThis study followed 302 children with juvenile idiopathic arthritis (JIA) who had previously taken tofacitinib in earlier studies. The goal was to see how safe the drug is over the long term, by tracking side effects, lab results, and growth. Children took tofacitinib twice daily…
Phase: PHASE2, PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Engineered immune cells take on lupus in first human test
Disease control CompletedThis early-stage trial tested a new treatment for people with severe lupus that did not get better with standard medicines. The treatment uses a patient's own immune cells, modified in a lab to target and attack faulty immune cells causing the disease. Only 3 people took part, an…
Phase: PHASE1 • Sponsor: Chulalongkorn University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Kids with quiet arthritis may taper meds without Flare-Ups, study finds
Disease control CompletedThis study looked at 62 children with juvenile idiopathic arthritis whose disease was inactive. Researchers tested whether slowly reducing and then stopping their biologic medication was as safe and effective as staying on the full dose for 24 weeks. The goal was to see if taperi…
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New combo therapy aims to shrink spleens in bone marrow cancer patients
Disease control CompletedThis study tested whether adding the experimental drug navitoclax to the standard drug ruxolitinib works better than ruxolitinib alone for people with myelofibrosis, a type of bone marrow cancer. The main goal was to see if the combination could shrink an enlarged spleen by at le…
Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Cord blood boost: new technique shows promise for tough leukemia cases
Disease control CompletedThis study tested a new way to prepare cord blood for transplant in 30 people with high-risk leukemia or myelodysplasia. The cord blood was treated with a molecule called UM171 to help it grow more stem cells. The goal was to see if this approach is safe and helps patients recove…
Phase: PHASE2 • Sponsor: ExCellThera inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Can kids with cancer stop antibiotics sooner? new trial investigates
Disease control CompletedThis study looked at whether children with cancer and a fever caused by low white blood cells can safely stop antibiotics earlier than usual. 55 children took part, and half stopped antibiotics once their fever was gone for 48 hours, while the other half continued until their whi…
Phase: PHASE4 • Sponsor: Murdoch Childrens Research Institute • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New lupus pill shows promise in Long-Term safety trial
Disease control CompletedThis completed Phase 2 trial tested the long-term safety of deucravacitinib (BMS-986165), a daily pill, in 261 people with systemic lupus erythematosus (SLE). Participants had already completed an earlier study and continued taking the drug to monitor side effects and lab abnorma…
Phase: PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New hope for leukemia patients: asciminib shows promise in phase 3 trial
Disease control CompletedThis study tested the drug asciminib in 199 adults with chronic myeloid leukemia (CML) whose cancer was not well controlled after trying at least two other targeted therapies. The main goal was to see how many patients achieved a major molecular response (a key sign of disease co…
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New shot could ease back pain for ankylosing spondylitis patients
Disease control CompletedThis study tested a drug called AK111 in 510 adults with active ankylosing spondylitis, a type of arthritis that causes back pain and stiffness. Participants received either AK111 or a placebo as a shot under the skin over 48 weeks. The main goal was to see if AK111 improves symp…
Phase: PHASE3 • Sponsor: Akeso • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New Two-Step transplant shows promise for tough blood cancers
Disease control CompletedThis phase 2 trial tested a two-step stem cell transplant approach for 47 patients with high-risk blood cancers like leukemia and lymphoma. The method uses the drug cyclophosphamide to lower the chance of graft-versus-host disease (GVHD), a common complication. The goal was to se…
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New scleroderma pill shows promise in slowing lung damage
Disease control CompletedThis study tested a medicine called Avenciguat (BI 685509) in 214 adults with scleroderma, a disease that can cause skin hardening and lung or blood vessel damage. Participants took either the study drug or a placebo three times daily for at least 11 months. Researchers measured …
Phase: PHASE2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New dosing study aims to tame Drug-Resistant leukemia
Disease control CompletedThis study tested three different starting doses (45 mg, 30 mg, and 15 mg daily) of the drug ponatinib in 283 adults with chronic phase chronic myeloid leukemia (CML) that had stopped responding to other treatments or had a specific genetic mutation (T315I). The main goal was to …
Phase: PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Last-resort leukemia combo shows early promise in tiny trial
Disease control CompletedThis early-phase study tested a combination of two drugs, venetoclax and omacetaxine, in 6 adults with acute myeloid leukemia (AML) whose cancer had stopped responding to venetoclax-based treatments. The main goal was to find the safest dose of omacetaxine when given with venetoc…
Phase: PHASE1 • Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New hope for scleroderma: arthritis drug tofacitinib tested against skin thickening
Disease control CompletedThis study tested whether tofacitinib (a JAK inhibitor drug) works better than methotrexate (a standard treatment) at reducing skin thickening in people with a severe form of scleroderma called diffuse cutaneous systemic sclerosis. Thirty-four adults with early-stage disease took…
Phase: PHASE4 • Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Microtransplant without immune drugs shows promise for leukemia patients too sick for standard transplant
Disease control CompletedThis early-phase trial tested a new type of stem cell transplant called a microtransplant in 25 people with myeloid blood cancers (like leukemia) who were too old or frail for a standard transplant. Unlike a regular transplant, this one used stem cells from a partially matched fa…
Phase: PHASE1 • Sponsor: Institut Paoli-Calmettes • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Lupus kids get CoQ10 boost in new trial
Disease control CompletedThis study tested whether taking coenzyme Q10 (a natural supplement) along with standard lupus treatment can improve health in children with lupus. Sixty children aged 6-16 with moderate to severe lupus took either CoQ10 or a placebo for 3 months. Researchers measured changes in …
Phase: PHASE2 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Old drugs, new hope: imatinib combo tested for rare tumors
Disease control CompletedThis early-phase trial tested two cancer drugs—imatinib mesylate and cyclophosphamide—given daily by mouth to 26 people with rare, advanced tumors that had no standard treatment. The main goal was to find the safest dose of imatinib when combined with a fixed dose of cyclophospha…
Phase: PHASE1 • Sponsor: Centre Oscar Lambret • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Lupus navigator program aims to close care gaps for minority patients
Disease control CompletedThis study tested a program where a patient navigator helped minority adults with lupus overcome barriers to care, like scheduling appointments, arranging transportation, and understanding their health. The goal was to see if this support could improve quality of life and medicat…
Phase: NA • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New hope for kids with lupus: drug study shows promise
Disease control CompletedThis early-stage study tested a drug called telitacicept in 16 children with lupus. The goal was to see how the drug moves through the body and if it helps control the disease. While not a cure, it may offer a new way to manage lupus symptoms in young patients.
Phase: PHASE1 • Sponsor: RemeGen Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Tailoring chemo by genetics and health may boost survival in older AML patients
Disease control CompletedThis study tested whether matching chemotherapy intensity to a patient's genetic risk and overall health could improve outcomes for older adults (60+) with acute myeloid leukemia. 75 participants received either standard intensive or lower-intensity chemo based on their individua…
Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New drug combo shows promise for Hard-to-Treat bone marrow disease
Disease control CompletedThis early-phase trial tested a combination of two drugs, ibrutinib and lenalidomide, in 4 patients with myelodysplastic syndrome (MDS) who had not responded to or could not tolerate standard treatments. The main goal was to find the safest dose and identify side effects. While t…
Phase: PHASE1 • Sponsor: University of California, Davis • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
PRP injection shows promise for shoulder tendon healing
Disease control CompletedThis study tested whether platelet-rich plasma (PRP) can improve tendon healing in people with a torn rotator cuff. Forty adults having arthroscopic repair surgery were split into two groups: one received PRP during surgery, the other did not. Researchers compared tendon tissue s…
Phase: PHASE1 • Sponsor: Aristotle University Of Thessaloniki • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New imaging tests aim to pinpoint the source of mysterious muscle pain
Diagnosis CompletedThis study is working to create a reliable imaging test to find and measure problem areas in muscle and fascia tissue, known as myofascial pain. Researchers will use ultrasound and MRI to identify unique 'biosignatures' in 120 people with plantar fasciitis, Achilles tendinopathy,…
Phase: NA • Sponsor: Ruth Chimenti • Aim: Diagnosis
Last updated Jul 04, 2026 00:00 UTC
-
New 25-Minute bone scan could spot cancer faster with less radiation
Diagnosis CompletedThis study tested a new 3D bone scan camera (VERITON-CT) that takes only 25 minutes and uses less radiation than standard scans. Researchers compared it to conventional 2D scans in 146 people with suspected or known bone metastases. The goal was to see if the new method could acc…
Phase: NA • Sponsor: Central Hospital, Nancy, France • Aim: Diagnosis
Last updated Jun 27, 2026 14:03 UTC
-
New imaging tool could help spot cancerous bone tumors earlier
Diagnosis CompletedThis study tested a new structured reporting system called BTI-RADS to help doctors better assess bone tumors from X-rays, CT, and MRI scans. Researchers analyzed images from 1,100 patients to see if the tool could more accurately tell which tumors are likely cancerous. The goal …
Sponsor: Central Hospital, Nancy, France • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
Radiation-Free lung MRI could change how we diagnose scarring lung disease
Diagnosis CompletedThis study tested whether a special lung MRI can replace CT scans for diagnosing idiopathic pulmonary fibrosis (IPF), a scarring lung disease. Researchers compared MRI to standard CT in 60 patients to see if MRI could spot the same key signs of IPF without using radiation. The go…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Diagnosis
Last updated Jun 27, 2026 12:35 UTC
-
New MRI method could spot lung damage without radiation
Diagnosis CompletedThis study tested whether MRI can detect and monitor interstitial lung disease (lung scarring) in people with scleroderma. Twenty-five adults with scleroderma underwent both MRI and CT scans. A subset also breathed in a special xenon gas to see how well their lungs exchange oxyge…
Sponsor: University of Kansas Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 12:28 UTC
-
New biopsy technique may boost sarcoidosis diagnosis rates
Diagnosis CompletedThis study tested whether adding a tiny forceps biopsy to the standard needle biopsy during a lung ultrasound procedure helps doctors diagnose sarcoidosis more often. Fifty-five adults with enlarged lymph nodes in the chest took part. The goal was to see if the combined approach …
Phase: NA • Sponsor: George Washington University • Aim: Diagnosis
Last updated Jun 27, 2026 12:07 UTC
-
MRI could spot rheumatoid arthritis months earlier
Diagnosis CompletedThis study looked at whether an MRI scan can help doctors diagnose rheumatoid arthritis (RA) sooner in people with joint swelling. 75 adults with early symptoms were given an MRI and followed for a year. The goal was to see if MRI findings could predict who would develop RA, allo…
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 12:06 UTC
-
MRI may replace needle biopsy for muscle disease diagnosis
Diagnosis CompletedThis study looked at whether whole body MRI can accurately diagnose inflammatory myopathies—a group of muscle diseases causing weakness and damage. Researchers compared MRI results with muscle biopsies in 139 people suspected of having these conditions. If MRI proves reliable, it…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Jun 27, 2026 12:02 UTC
-
New knee tensioner aims to improve replacement outcomes
Symptom relief CompletedThis study is testing a device called the CORI™ KNEE TENSIONER, which helps surgeons balance the knee during total knee replacement surgery. Fifty adults who need a knee replacement will have the surgery using this device, and their recovery and quality of life will be tracked fo…
Phase: NA • Sponsor: Smith & Nephew, Inc. • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Shockwave therapy shows promise for soothing heel pain
Symptom relief CompletedThis completed study looked at whether extracorporeal shockwave therapy can improve quality of life and reduce pain in people with plantar fasciitis, a common cause of heel pain. Researchers enrolled 175 adults aged 25 to 59 who had heel pain for at least three months. The therap…
Sponsor: Adly A Adam • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Ancient needle therapy takes on chronic bladder pain
Symptom relief CompletedThis study investigates whether acupuncture can relieve symptoms and improve quality of life in women diagnosed with treatment-resistant interstitial cystitis/bladder pain syndrome. Participants receive eight sessions of acupuncture over four weeks at specific points on the body.…
Phase: NA • Sponsor: Medipol University • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Nerve gliding exercises may amplify shock wave therapy for stubborn heel pain
Symptom relief CompletedThis study tests whether adding neural gliding exercises—gentle movements that help nerves slide smoothly—to standard shock wave therapy and home exercises can further reduce pain and improve foot function in people with plantar fasciitis. About 56 adults with this common cause o…
Phase: NA • Sponsor: Ankara Yildirim Beyazıt University • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
Laser or ultrasound: which zaps heel pain best?
Symptom relief CompletedThis study tested two device-based treatments—high-intensity laser and high-power ultrasound—against standard care for plantar fasciitis. 51 adults with heel pain for at least a month received one of the therapies three times a week for a month. Researchers measured pain levels a…
Phase: NA • Sponsor: Cairo University • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
New combo therapy aims to ease jumper's knee pain
Symptom relief CompletedThis study tested whether adding a nerve-stimulating technique (ultrasound-guided percutaneous neuromodulation) to standard treatments (electrolysis and eccentric exercises) helps athletes with jumper's knee. 26 adults aged 18-50 who played sports at least 3 times a week and had …
Phase: NA • Sponsor: Universidad de Zaragoza • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Can a structured support program ease the first year of juvenile arthritis?
Symptom relief CompletedThis study tested a one-year support program (JASP-1) for children newly diagnosed with juvenile idiopathic arthritis (JIA). The program included seven structured visits with a focus on the child and family. Researchers compared registry data from 56 children who took part in the…
Phase: NA • Sponsor: Region Stockholm • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Could online pilates ease pain for those with stretchy joints?
Symptom relief CompletedThis study investigates whether an online Pilates program designed for people with hypermobile Ehlers-Danlos syndrome or hypermobility spectrum disorder can reduce pain and improve function. Participants follow 25-minute guided videos three times a week for eight weeks. Researche…
Phase: NA • Sponsor: Clarkson University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
App eases psoriasis burden in landmark trial
Symptom relief CompletedThis study tested a self-guided online program for people with psoriasis. 348 adults were split into two groups: one got the app plus their regular treatment, the other got regular treatment alone. The main goal was to see if the app improved quality of life over 12 months.
Phase: NA • Sponsor: Gaia AG • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Can special exercises ease back pain from scoliosis?
Symptom relief CompletedThis study tested two different exercise approaches in 34 people aged 11–24 with idiopathic scoliosis and chronic low back pain. Researchers measured changes in back muscle tissue thickness, pain levels, and daily function. The goal was to see which exercise method works better f…
Phase: NA • Sponsor: Hacettepe University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Shock wave vs vibration: which soothes heel pain best?
Symptom relief CompletedThis study compared two treatments for plantar fasciitis, a common cause of heel pain: shock wave therapy and whole body vibration. Sixty adults with heel pain for at least 4 weeks were randomly assigned to one of the treatments. The goal was to see which better reduces pain and …
Phase: NA • Sponsor: Gaziosmanpasa Research and Education Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Ear device may tame arthritis pain without drugs
Symptom relief CompletedThis study tested whether a device that gently stimulates the vagus nerve through the ear could help control rheumatoid arthritis in one patient who had their spleen removed. The patient used the device at home for 24 months and visited the clinic every two months for checkups. T…
Phase: NA • Sponsor: Osteoflow Health Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Nurse sessions may help arthritis patients handle biologic drugs safely
Symptom relief CompletedThis study tested whether nurse-led consultations can help people with rheumatoid arthritis become more independent in managing their subcutaneous biotherapy. Many patients struggle to recognize warning signs and delay seeking help. The study enrolled 71 adults with rheumatoid ar…
Phase: NA • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Ancient chinese practice tested to ease lupus fatigue and stress
Symptom relief CompletedThis study tested whether practicing Qi Gong, a gentle mind-body exercise, could improve quality of life in people with systemic lupus erythematosus (SLE). Thirty-three participants took part in weekly Qi Gong sessions for six months. Researchers measured changes in physical func…
Phase: NA • Sponsor: University Hospital, Limoges • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Ear stimulation device shows promise for Ehlers-Danlos relief
Symptom relief CompletedThis study tested whether a small, at-home device that stimulates a nerve in the ear can improve symptoms like pain, fatigue, sleep, and mood in people with hypermobile Ehlers-Danlos syndrome (hEDS). Twenty-five adults with hEDS used the device daily for two weeks, with some rece…
Phase: NA • Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
Can a blood vessel drug ease Raynaud's in scleroderma?
Symptom relief CompletedThis Phase 2 trial tested whether selexipag, a drug that opens blood vessels, can reduce the number of Raynaud's attacks in adults with systemic sclerosis. 74 participants took either selexipag or a placebo twice daily. The main goal was to see if the drug lowered weekly attack f…
Phase: PHASE2 • Sponsor: Actelion • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
Heel pain showdown: gentle touch vs. tennis ball – which eases plantar fasciitis best?
Symptom relief CompletedThis study tested two simple, non-invasive treatments for plantar fasciitis, a common cause of heel pain. Eighty adults aged 20–50 with heel pain lasting over 4 weeks were split into two groups: one received Bowen therapy (a gentle hands-on technique) twice weekly for 12 weeks, w…
Phase: NA • Sponsor: Green International University • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Could a simple ear device ease hEDS symptoms?
Symptom relief CompletedThis study tested a wearable device that delivers mild electrical stimulation to the ear in 30 adults with hypermobile Ehlers-Danlos syndrome (hEDS). The goal was to see if it could improve quality of life by reducing symptoms like pain, fatigue, sleep problems, and anxiety. Part…
Phase: NA • Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Simple core workouts may tame pain and fatigue in kids with arthritis
Symptom relief CompletedThis study compares core stabilization exercises to a daily physical activity program in children aged 10-18 with juvenile spondyloarthropathy, a type of arthritis. The goal is to see if targeted core training can reduce pain, fatigue, and improve quality of life better than gene…
Phase: NA • Sponsor: Istanbul University - Cerrahpasa • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New shot targets cellulite: small study tests qwo on butt and thighs
Symptom relief CompletedThis completed Phase 4 study tested multiple doses of Qwo, a drug made from bacterial enzymes, for treating mild to moderate cellulite in adult women. Five participants received injections in their buttocks and thighs over three sessions. The goal was to see if the treatment impr…
Phase: PHASE4 • Sponsor: DMR Research, PLLC • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
Can muscle feedback or electrical stimulation help kids move better after brain tumor surgery?
Symptom relief CompletedThis study compared two therapies—myofeedback and neuromuscular electrical stimulation—to see which better improves arm and hand function in children aged 6 to 14 who have one-sided weakness (hemiplegia) after brain tumor surgery. Forty-five children participated, and researchers…
Phase: NA • Sponsor: Cairo University • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
Can mindfulness ease arthritis pain? small study seeks answers
Symptom relief CompletedThis completed pilot study tested an 8-week online mindfulness course in 38 people with rheumatoid arthritis. The goal was to see if patients liked the program, what barriers they faced, and how it might affect symptoms. Half the group took the course while the other half receive…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Blood flow or scraping: which eases shoulder pain best?
Symptom relief CompletedThis study tested two different therapies for rotator cuff tendinopathy, a common cause of shoulder pain. Thirty-four patients received either blood flow restriction therapy or gua sha scraping, both combined with exercises, twice a week for six weeks. The goal was to see which a…
Phase: NA • Sponsor: Elite College of Management Sciences, Gujranwala, Pakistan • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Simple exercises may soothe stubborn thumb pain without surgery
Symptom relief CompletedThis study tested whether a structured eccentric training program—exercises that lengthen the muscle under load—could reduce pain and improve hand function in 25 adults with de Quervain's tendinopathy who had not gotten better with other treatments. Participants did the exercises…
Phase: NA • Sponsor: Dr. Lenti Katalin • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Taping or no taping? new study tests best way to soothe heel spur pain
Symptom relief CompletedThis study tested two physical therapy approaches for people with painful heel spurs. 38 adults received either myofascial release alone or myofascial release plus taping over several weeks. The goal was to see which method better reduces pain and improves foot function. Results …
Phase: NA • Sponsor: Green International University • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Wrestlers try Brain-Training exercises to heal shoulder pain
Symptom relief CompletedThis study tested a new exercise method called Tendon Neuroplastic Training (TNT) in 26 wrestlers with shoulder tendinopathy. TNT uses a smartphone metronome to pace exercises, aiming to improve brain-muscle control. The goal was to see if it could boost shoulder function, balanc…
Phase: NA • Sponsor: Hacettepe University • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
New dental paste shows promise for soothing dry socket pain
Symptom relief CompletedThis study tested a dental paste called Alveogyl in 120 people who developed a dry socket after a tooth extraction. The paste is placed into the socket by a dentist to relieve pain and help the gum heal. Researchers measured pain levels and healing over 7 days. The trial is alrea…
Sponsor: Septodont • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
Pilates put to the test for achilles pain relief
Symptom relief CompletedThis study looked at whether Pilates exercises can help people with Achilles tendinopathy, a condition causing pain and swelling in the back of the ankle. Researchers compared Pilates to standard eccentric exercises in 49 adults. The goal was to see if Pilates could reduce pain a…
Phase: NA • Sponsor: University of West Attica • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
Could a dab of antibiotic gel replace pills after wisdom tooth removal?
Symptom relief CompletedThis study tested whether applying antibiotics directly into the tooth socket after wisdom tooth removal works as well as taking antibiotic pills. 90 adults having their lower wisdom teeth taken out were split into two groups: one got antibiotic gel at the surgery site, the other…
Phase: PHASE4 • Sponsor: Liaquat College of Medicine and Dentistry • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
Water-Jet tool zaps tennis elbow pain in small trial
Symptom relief CompletedThis study tested a new, less invasive surgery for tennis elbow. 29 adults with chronic elbow pain received a water-jet procedure guided by ultrasound. Researchers measured pain and function changes over 12 months to see if the treatment helped.
Sponsor: HydroCision, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Fun and fitness: VR games may boost Kids' activity levels
Symptom relief CompletedThis study looked at whether aerobic exercise and virtual reality games could improve functional capacity, activity, and participation in children aged 6-10 living in care facilities. Sixty-three children were split into groups: one did aerobic exercise, one played VR games, and …
Phase: NA • Sponsor: Hasan Kalyoncu University • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Vitamin cocktail may shrink fibroids, reduce surgery need
Symptom relief CompletedThis study tested a 3-month treatment with a combination of vitamin D, green tea extract (EGCG), vitamin B6, and D-Chiro-inositol in 108 women with uterine fibroids who were planning surgery. The goal was to see if the supplement could ease symptoms and possibly help some women a…
Phase: NA • Sponsor: Universita di Verona • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Home workouts for scleroderma lungs show promise in small pilot study
Symptom relief CompletedThis study tested whether a personalized home respiratory rehabilitation program is feasible for people with systemic sclerosis (scleroderma) who have early lung disease. Fifteen participants completed a 3-month program with one supervised session followed by home exercises. The …
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Lupus pain drug shows promise in early trial
Symptom relief CompletedThis phase 2 study tested whether JBT-101 (lenabasum) can reduce joint pain in people with systemic lupus erythematosus (SLE). 109 adults with active arthritis and at least moderate pain took either the drug or a placebo for 84 days. The main goal was to see if pain scores improv…
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Cancer drug repurposed to fight rare skin disease in small safety trial
Symptom relief CompletedThis early-phase study tested whether a drug used for lymphoma, brentuximab vedotin, is safe for people with a severe form of scleroderma (diffuse cutaneous systemic sclerosis). The drug targets overactive immune cells that may drive the disease. Only 17 people took part, and the…
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Laser light eases shoulder pain in new study
Symptom relief CompletedThis study tested whether low-intensity laser therapy can reduce shoulder pain caused by inflammation of the supraspinatus tendon. Forty adults with confirmed tendinopathy received laser treatment over three months. Researchers measured pain levels, shoulder movement, and quality…
Phase: NA • Sponsor: Universidad Pontificia de Salamanca • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Heel pain showdown: surgery or exercise for plantar fasciitis?
Symptom relief CompletedThis study tested whether surgery (radiofrequency microtenotomy) or non-surgical treatment (strength training) works better for chronic plantar fasciitis—a common cause of heel pain. 70 adults with heel pain lasting over 7 months took part. The main goal was to see which approach…
Phase: NA • Sponsor: University of Southern Denmark • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Can an app beat fatigue in scleroderma? small study tests feasibility
Symptom relief CompletedThis study tested a smartphone app called RENEW designed to help people with scleroderma manage fatigue and build resilience. Over 12 weeks, 43 participants used the app to set and track weekly healthy goals. The main goal was to see if people would actually use the app and compl…
Phase: NA • Sponsor: University of Michigan • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Sugar water injection may ease shoulder pain better than TENS
Symptom relief CompletedThis study tested a new injection treatment called PIT (using a sugar-water solution) against TENS (a mild electrical stimulation device) for people with shoulder pain. Thirty-two adults with ongoing shoulder pain received either PIT or TENS, plus exercises, over two weeks. The g…
Phase: NA • Sponsor: Rizki Darmawan • Aim: Symptom relief
Last updated Jun 27, 2026 12:26 UTC
-
New device AVELI tackles cellulite and fibrosis in liposuction patients
Symptom relief CompletedThis study tested a device called AVELI to safely reduce cellulite and fibrous tissue in 130 people undergoing body contouring surgery. Researchers measured safety, patient satisfaction, and appearance improvements over 9 months. The goal was to see if adding AVELI to standard li…
Phase: NA • Sponsor: Total Definer Research Group • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
New study tests best method to cut bleeding in fibroid surgery
Symptom relief CompletedThis study looked at 120 women having open surgery for uterine fibroids to see which method best reduces bleeding. Doctors compared using a tourniquet, clamping the uterine artery, or no compression at all. The goal is to find the safest way to control blood loss and improve reco…
Phase: NA • Sponsor: Yuzuncu Yil University • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Supplements and exercise show promise for kids with muscle disease
Symptom relief CompletedThis study looked at whether taking creatine and coenzyme Q10 supplements, along with exercise, could help children with juvenile myositis (a disease that causes muscle weakness and fatigue). Fifteen children aged 7 to 18 took part. The goal was to see if these supplements could …
Phase: NA • Sponsor: The Hospital for Sick Children • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Cold therapy offers simple pain relief for arthritis patients
Symptom relief CompletedThis study tested whether applying cold to painful joints can reduce pain and improve quality of life in people with rheumatoid arthritis. 90 patients with active pain participated. The goal was to see if this simple, low-cost method could be a helpful addition to standard care.
Phase: NA • Sponsor: Saglik Bilimleri Universitesi • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Zapping acupoints may ease period pain for autoimmune patients
Symptom relief CompletedThis study tested whether transcutaneous electrical acupoint stimulation (TEAS) — a gentle electrical pulse applied to specific points on the body — could reduce period pain and inflammation in women with autoimmune diseases like rheumatoid arthritis or lupus. Fifty-two women rec…
Phase: NA • Sponsor: Cairo University • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Warm water on feet may ease Pre-Surgery jitters
Symptom relief CompletedThis study tested whether soaking feet in warm water for 20 minutes before pituitary tumor surgery helps patients feel less anxious and keeps vital signs stable. 100 adults were enrolled, with one group receiving the foot bath and the other standard care. Researchers measured anx…
Phase: NA • Sponsor: Trakya University • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Could a placenta injection heal stubborn achilles pain?
Symptom relief CompletedThis study tested a special injection made from donated placenta tissue in 20 people with long-lasting Achilles tendon pain that didn't get better with standard treatments like physical therapy. The goal was to see if the injection could reduce pain and improve function. Results …
Phase: NA • Sponsor: North Park Podiatry • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Could a blood injection boost shoulder healing?
Symptom relief CompletedThis study looked at 80 people with painful calcium deposits in the shoulder tendon that didn't get better with standard care. All received a needle procedure to remove the deposits, and half also got an injection of their own platelet-rich plasma (PRP). The goal was to see if ad…
Phase: NA • Sponsor: Orthopedisch Centrum Oost Nederland • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Can a Stress-Management program help young cancer patients cope?
Symptom relief CompletedThis study tested whether a program called PRISM (Promoting Resilience in Stress Management) could help young adults aged 18-39 who have cancer or desmoid tumors manage anxiety and depression. The program teaches skills like stress management, goal setting, and positive thinking.…
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Can a common Alzheimer's drug clear lupus brain fog?
Symptom relief CompletedThis study tested whether memantine, a drug used for Alzheimer's, can help with thinking and memory problems in people with lupus. About 111 adults with lupus and cognitive issues took either memantine or a placebo for 14 weeks. The goal was to see if the drug safely improves bra…
Phase: PHASE2 • Sponsor: Vanderbilt University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Could a single injection from donated tissue ease knee arthritis pain?
Symptom relief CompletedThis study tested whether a single injection of amniotic suspension allograft (ASA) can reduce pain and improve function in adults with knee osteoarthritis who haven't found relief from other treatments. About 594 participants received either ASA or a placebo, and their pain and …
Phase: PHASE3 • Sponsor: Organogenesis • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Dietary formula shows promise for psoriatic arthritis symptom relief
Symptom relief CompletedThis study tested whether a food formula containing medium-chain triglycerides (MCTs) and vegetable fibers could improve quality of life in 72 adults with psoriatic arthritis and low disease activity. Participants took the formula for 3 months while continuing their usual medicat…
Phase: NA • Sponsor: Dr. Schär AG / SPA • Aim: Symptom relief
Last updated Jun 27, 2026 12:10 UTC
-
Could light and simple hand exercises help kids with scleroderma?
Symptom relief CompletedThis study tested whether polarized light therapy combined with hand grip strengthening exercises can help children aged 8 to 11 with localized scleroderma affecting their hands. Twenty-one children took part, doing either resisted hand exercises, light therapy plus exercises, or…
Phase: NA • Sponsor: New Ismailia National University • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
New study tests better pain control during brain surgery
Symptom relief CompletedThis study looked at two ways to numb a nerve bundle in the face during pituitary gland surgery. The goal was to see which method reduces the amount of anesthesia needed during the operation. Sixty adults having this type of surgery took part. The results help doctors choose the …
Phase: NA • Sponsor: Donia Hany Saad • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
New vaginal surgery technique may reduce pain after hysterectomy
Symptom relief CompletedThis study compared two types of minimally invasive hysterectomy: vNOTES (done through the vagina) and conventional laparoscopic hysterectomy (done through small belly cuts). About 90 women having hysterectomy for non-cancer reasons took part. The goal was to see which method cau…
Phase: NA • Sponsor: Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
Can your own blood ease back pain? PRP vs steroids for sacroiliac joints
Symptom relief CompletedThis study compared two injections for sacroiliac joint pain: platelet-rich plasma (PRP) made from the patient's own blood, and a standard steroid/anesthetic mix. Fifty adults with confirmed sacroiliac joint pain received one of the two injections. Researchers measured pain level…
Phase: NA • Sponsor: University of Utah • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
New laser combo eases tight mouths in rare skin disease
Symptom relief CompletedThis small study tested a new way to treat microstomia (a tight, small mouth) caused by scleroderma. Three adults received three sessions of a laser treatment that delivered hyaluronidase, an enzyme that breaks down tight tissue, directly into the skin. The goal was to improve mo…
Phase: EARLY_PHASE1 • Sponsor: University of Nebraska • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Step by step: walking program shows promise for lupus fatigue
Symptom relief CompletedThis study tested whether a simple walking program using a pedometer could help reduce fatigue and improve quality of life in people with lupus. 101 participants were randomly assigned to either a walking group with personalized step goals or a wait-list control group. The progra…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
Can a smartphone app ease rheumatoid arthritis symptoms?
Symptom relief CompletedThis study tested a mobile app designed to help people with rheumatoid arthritis manage their condition. 90 adults with stable treatment used the app for 12 weeks, while a control group received usual care. Researchers measured changes in disease activity and quality of life to s…
Phase: NA • Sponsor: Kırıkkale University • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
Ancient remedy dharasana lep tested for pain relief in small study
Symptom relief CompletedThis study tested a treatment called Dharasana Lep in 35 adults with mild to moderate muscle or joint pain, including rheumatoid arthritis. The goal was to see if it safely reduces pain and improves movement. Participants used the treatment and reported their pain levels using si…
Phase: NA • Sponsor: NovoBliss Research Pvt Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
Elastic band trick may ease achilles pain, small study finds
Symptom relief CompletedThis study looked at whether adding a technique called tissue flossing (wrapping an elastic band around the lower leg and doing exercises) to standard heel-drop exercises can reduce pain and improve movement in people with Achilles tendinopathy. Thirty adults aged 20-45 with long…
Phase: NA • Sponsor: Riphah International University • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Fasting for clearer skin? study tests Time-Restricted eating for psoriasis
Symptom relief CompletedThis study looked at whether intermittent fasting (eating only during certain hours) can reduce disease severity and improve quality of life for people with psoriasis and psoriatic arthritis. Sixty overweight adults were randomly assigned to either follow an intermittent fasting …
Phase: NA • Sponsor: Ohio State University • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Heel pain hope: collagen shots tested for stubborn plantar fasciitis
Symptom relief CompletedThis study tested whether injecting collagen into the heel can safely ease pain from chronic plantar fasciitis. Sixty adults who had not improved with other treatments received either collagen or a placebo injection. Researchers measured pain levels and heel thickness over 12 mon…
Phase: NA • Sponsor: Cellontech Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
Lung rehab boosts daily activity in advanced sarcoidosis patients
Symptom relief CompletedThis study looked at whether a pulmonary rehabilitation program helps people with Stage IV pulmonary sarcoidosis (advanced lung scarring) become more active in their daily lives. 38 adults took part and were followed for one year. The program aimed to improve exercise ability, re…
Phase: NA • Sponsor: University Hospital, Lille • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
Heel pain showdown: which therapy wins for plantar fasciitis?
Symptom relief CompletedThis study tested two treatments—fascial manipulation and dry needling—in 36 women aged 25-45 with chronic plantar fasciitis (long-term heel pain). Participants received one of the treatments twice a week for six weeks. The goal was to see which method better reduces pain and imp…
Phase: NA • Sponsor: Riphah International University • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Laser zaps face veins in scleroderma patients – 21 test it out
Symptom relief CompletedThis study tested a pulsed dye laser to reduce red veins (telangiectasias) on the face and neck in 21 people with scleroderma. Participants received four laser sessions, and the researchers checked how many veins disappeared, how patients felt about the results, and any side effe…
Phase: NA • Sponsor: University Hospital, Caen • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Which exercise focus works best for kids with rheumatic conditions?
Symptom relief CompletedThis study tested two different exercise programs in 28 children and teens with rheumatic diseases like juvenile arthritis and familial Mediterranean fever. One program used external focus (thinking about the movement's effect), the other used internal focus (thinking about the b…
Phase: NA • Sponsor: Istanbul University - Cerrahpasa • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Joint injection showdown: etanercept vs steroid for RA Flare-Ups
Symptom relief CompletedThis study tested whether an injection of etanercept, a targeted anti-inflammatory drug, works better than a standard steroid injection for sudden joint swelling in people with rheumatoid arthritis. 34 adults with active arthritis in a knee, wrist, ankle, or elbow took part. The …
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Acupuncture before surgery may steady blood pressure in hysterectomy patients
Symptom relief CompletedThis small pilot study looked at whether acupuncture given twice before surgery could help stabilize blood pressure in women having their uterus removed (total laparoscopic hysterectomy) for fibroids. Thirty-five adult patients received acupuncture before the operation, and resea…
Phase: NA • Sponsor: Ilsan Cha hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
New shot could ease pain of plantar fibromatosis
Symptom relief CompletedThis study tested an injection called EN3835 against a placebo in 176 people with plantar fibromatosis, a condition causing painful lumps on the soles of the feet. The goal was to see if EN3835 reduces foot pain and improves daily function over 57 days. Participants received up t…
Phase: PHASE2 • Sponsor: Endo USA Inc., a Keenova Therapeutics Company • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Heart-Smart chemo: new infusion method aims to protect AML patients
Symptom relief CompletedThis early-stage study looked at whether giving two standard chemotherapy drugs (cytarabine and daunorubicin) in a different way could be safer for the heart in adults newly diagnosed with acute myeloid leukemia (AML). Researchers used heart MRI scans to monitor for damage. The g…
Phase: PHASE1 • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Foam rolling or special tools: which eases heel pain best?
Symptom relief CompletedThis study tested two hands-on treatments for chronic plantar fasciitis, a common cause of heel pain. Fifty-six adults received either instrument-assisted soft tissue mobilization or foam rolling, plus exercises. The goal was to see which approach better reduces pain, improves an…
Phase: NA • Sponsor: Manav Rachna International Institute of Research and Studies • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Simple hand exercises show promise for arthritis sufferers
Symptom relief CompletedThis study tested a hand exercise program called SARAH in 6 women with rheumatoid arthritis. The program includes strengthening, stretching, and home exercises along with education. The goal was to see if it improves hand function and reduces pain.
Phase: NA • Sponsor: Federal University of Espirito Santo • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
New hope for women with vestibulodynia: cream and pill combo under study
Symptom relief CompletedThis study tested two treatments for vestibulodynia, a chronic pain condition affecting the vulvar area. 209 women received either a lidocaine/estradiol cream, the antidepressant nortriptyline, both, or a placebo. The goal was to see which approach best reduces pain and improves …
Phase: PHASE2 • Sponsor: Duke University • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Mind over matter: video education eases teen leg pain?
Symptom relief CompletedThis study looked at whether a video that teaches teens how fear and stress affect pain can help them recover from leg pain. 86 teens with leg pain for over a month took surveys and wore activity trackers. Half watched the special video, and all were followed for a year to see if…
Phase: NA • Sponsor: Nationwide Children's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
New study examines pain and adherence in patients switching to concentrated adalimumab
Symptom relief CompletedThis study involved 324 adults with conditions like Crohn's disease, arthritis, or psoriasis who switched from a standard to a higher-concentration form of adalimumab (AVT-02). Researchers measured injection site pain and how well patients stuck with their treatment over 180 days…
Sponsor: Jamp Pharma Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
New study: shoulder surgery helps older cancer patients move better and hurt less
Symptom relief CompletedThis study looked at 53 patients with cancer that spread to the upper arm bone, causing pain and limited movement. Researchers compared older and younger patients who had shoulder replacement surgery to see if age affected recovery. The goal was to find out if this surgery is saf…
Sponsor: Sichuan Provincial People's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Rehab program shows promise for scleroderma Patients' daily life
Symptom relief CompletedThis study tested whether a personalized rehabilitation program could improve quality of life for people with systemic sclerosis, a disease that causes skin and joint stiffness. 220 adults with the condition were randomly assigned to either the rehab program or usual care. The pr…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Can your own blood soothe dry eyes? new study says maybe.
Symptom relief CompletedThis study tested whether eye drops made from a patient's own blood (autologous serum) can relieve severe dry eye better than standard artificial tears. 46 adults with severe dry eye tried both diluted (20%) and full-strength (100%) serum drops, as well as artificial tears. The m…
Phase: NA • Sponsor: University Hospital, Ghent • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
New pill for bladder pain shows promise in early trial
Symptom relief CompletedThis early-stage study tested a drug called V117957 in 47 women with interstitial cystitis, a condition causing bladder pain and discomfort. Participants took either the drug or a placebo at bedtime to see if it safely reduced pain. The trial is now complete, and results will hel…
Phase: PHASE1 • Sponsor: Imbrium Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Ultrasound-Guided needle therapy shows promise for shoulder pain
Symptom relief CompletedThis study tested whether using ultrasound to guide a needle-based treatment (pharmacopuncture) helps reduce shoulder pain more than the same treatment without ultrasound. Forty adults with moderate to severe shoulder pain from a torn or damaged tendon took part. The goal was to …
Phase: NA • Sponsor: Jaseng Medical Foundation • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Heel pain breakthrough? exercise boosts steroid shot results
Symptom relief CompletedThis study looked at whether adding specific foot exercises to a standard corticosteroid injection provides extra relief for people with plantar fasciitis, a common cause of heel pain. Forty adults with heel pain for at least a month took part. Researchers measured pain, flexibil…
Phase: NA • Sponsor: Kutahya Health Sciences University • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Walking by phone: new study tests arthritis pain relief without the gym
Symptom relief CompletedThis study tested a phone-based version of the Walk With Ease program for 267 adults with arthritis, gout, fibromyalgia, rheumatoid arthritis, osteoarthritis, or lupus. Participants followed a 6-week walking program delivered by phone, and researchers measured changes in pain, ph…
Phase: NA • Sponsor: University of South Carolina • Aim: Symptom relief
Last updated Jun 27, 2026 09:11 UTC
-
Stretchy skin may reveal heart risks in rare genetic condition
Knowledge-focused CompletedThis study looked at how stretchy the skin and blood vessels are in people with Williams syndrome, a genetic condition that can cause heart problems. Researchers measured skin and pulse speed in 43 participants aged 5 to 70. The goal was to learn how these tissues change over tim…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Twin study seeks clues to rheumatic disease mysteries
Knowledge-focused CompletedThis study looks at families where one sibling has a rheumatic disease (like rheumatoid arthritis or lupus) and the other does not. Researchers compare their blood, genes, and environmental exposures to find clues about why one got sick. Over 1,000 participants are involved, incl…
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Scientists dive into rare cholesterol disorders to uncover clues
Knowledge-focused CompletedThis study looks at rare genetic disorders where the body can't make cholesterol properly, which can cause birth defects and learning problems. Researchers collect blood, urine, and tissue samples from affected people and their families to learn more about these conditions. The g…
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Researchers observe bone disorders to expand knowledge
Knowledge-focused CompletedThis study looked at people with suspected bone-related connective tissue disorders (like brittle bone disease) and their healthy family members. The goal was to learn more about these conditions, train doctors, and collect samples for future research. Participants received stand…
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Scientists uncover genetic secrets behind rare hormone disorders
Knowledge-focused CompletedThis study looked at nearly 1,400 people with rare conditions like PPNAD, Carney Complex, and Peutz-Jeghers syndrome. The goal was to find the genetic causes and link them to specific symptoms. Researchers used clinical exams and genetic testing to better understand how these dis…
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Small study aims to unlock secrets of rare lung disease
Knowledge-focused CompletedThis completed Phase 1 study looked at 27 people with and without pulmonary hypertension to learn more about how blood vessel problems contribute to the disease. Researchers used heart catheterization, imaging, and blood tests to find biomarkers and understand disease mechanisms.…
Phase: PHASE1 • Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Can your diet calm your arthritis? new study investigates
Knowledge-focused CompletedThis study is looking at how nutrition affects disease activity in people with rheumatic diseases like rheumatoid arthritis, lupus, and psoriatic arthritis. Researchers will measure the nutritional status of 460 participants using several different tools and compare it to how act…
Sponsor: Cairo University • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Real-World data reveals how bosutinib fights leukemia outside clinical trials
Knowledge-focused CompletedThis study looks back at medical records from a single hospital in Scotland to see how well the drug bosutinib works and how safe it is for people with chronic myeloid leukemia (CML) in everyday practice. Researchers will track blood cell counts, genetic responses, and side effec…
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Can flexible joints and flat feet worsen scoliosis? new study investigates
Knowledge-focused CompletedThis completed study examined 22 adolescents with idiopathic scoliosis to see if joint hypermobility (flexibility) and foot posture are linked to the severity of their spinal curve. Researchers measured hypermobility with the Beighton Score, foot posture with the Foot Posture Ind…
Sponsor: Istinye University • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
Tiny study aims to predict lupus flares before they strike
Knowledge-focused CompletedThis completed study enrolled 6 adults with systemic lupus erythematosus (SLE) to collect blood, urine, saliva, stool, and tissue samples over time. The goal was to find biological markers that could predict when a patient's disease might flare up or how they might respond to tre…
Sponsor: University Hospital, Brest • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
Could bendy joints be a clue in ADHD?
Knowledge-focused CompletedThis study looks at whether children with ADHD are more likely to have very flexible joints (benign joint hypermobility) and if a certain blood marker differs. Researchers will compare 171 children aged 6 to 12—some with ADHD and some without—using physical exams and blood tests.…
Sponsor: Antalya Training and Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Could a pneumonia drug boost leukemia treatment? small trial explores safety and dosing
Knowledge-focused CompletedThis early-phase trial tested whether adding atovaquone (a drug usually used to prevent pneumonia) to standard chemotherapy is safe and reaches effective levels in the blood. It involved 26 children and young adults (ages 1 month to 21 years) newly diagnosed with acute myeloid le…
Phase: EARLY_PHASE1 • Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Military myositis mystery: could exposures be the trigger?
Knowledge-focused CompletedThis study investigated whether environmental exposures during military service increase the risk of developing myositis, a rare autoimmune disease that attacks muscles. Researchers compared 37 military personnel with and without myositis using questionnaires and blood samples. N…
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Real-World study tests whether aggressive early treatment improves psoriatic arthritis outcomes
Knowledge-focused CompletedThis study follows people newly diagnosed with psoriatic arthritis (PsA) to see how a 'treat to target' approach works in everyday clinics. Participants receive standard care, often starting with methotrexate, and their disease activity is tracked over time. The goal is to unders…
Sponsor: University of Oxford • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Scientists hunt for genetic and environmental triggers of rare muscle diseases
Knowledge-focused CompletedThis study looked at 719 people, including patients with autoimmune connective tissue diseases like myositis, their blood relatives, and healthy volunteers. Researchers collected blood samples and medical histories to find genetic and environmental factors that may trigger these …
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Scientists probe acid 'Pain Channels' in arthritic joints
Knowledge-focused CompletedThis completed study from France examined joint fluid from 20 people with arthritis to see if acid-sensing ion channels (ASICs) play a role in pain. Researchers wanted to find natural compounds that activate these channels during inflammation. The goal is to validate ASICs as tar…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Immune cell study could pave way for new arthritis treatments
Knowledge-focused CompletedThis study looked at a type of immune cell called B regulatory cells in 100 people—some healthy and some with rheumatoid arthritis (RA). The goal was to understand how these cells differ between the two groups and how they might help control the disease. By identifying unique fea…
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
French study tracks Real-World use of TNF blockers in early arthritis
Knowledge-focused CompletedThis study followed 813 people with early rheumatoid arthritis in France to see how often and why doctors prescribe TNF blockers. Researchers tracked symptoms, joint damage, and treatment success over 5 years. The goal was to learn which patients benefit most and how well doctors…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Could natural immune cells help fight leukemia drug resistance?
Knowledge-focused CompletedThis completed study from France examined whether a specific type of immune cell (innate CD8+ T cells) is linked to how quickly resistance mutations develop in patients with chronic myeloid leukemia or Philadelphia-positive acute lymphoblastic leukemia. Researchers analyzed blood…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New insights on TNF blockers alone for early arthritis
Knowledge-focused CompletedThis study followed 813 people with early rheumatoid arthritis in France to see how often doctors prescribe TNF blockers alone (without other arthritis drugs) and how well they work. Researchers tracked symptoms, joint damage, and how long patients stayed on treatment over 5 year…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Can text messages help arthritis patients take their meds?
Knowledge-focused CompletedThis study looked at three ways to help people with rheumatoid arthritis take their methotrexate medication as prescribed: usual doctor visits, text message reminders, or a chat with a pharmacist. The goal was to see which method works best to improve adherence. The study include…
Phase: NA • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Are doctors following heart check rules for arthritis patients?
Knowledge-focused CompletedThis study looked at whether French doctors follow EULAR recommendations to check heart disease risk every year in patients with rheumatoid arthritis. Over 7000 patients were included. The goal was to see how often tests like blood sugar, cholesterol, and heart scans were prescri…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Could low vitamin c explain lingering pain in rheumatism and lupus?
Knowledge-focused CompletedThis study looks at whether people with chronic inflammatory rheumatism (like spondyloarthritis) or lupus who still have pain despite treatment have low vitamin C levels. Researchers will measure vitamin C in the blood and ask about pain, fatigue, and quality of life. The goal is…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Lung clues could unlock early rheumatoid arthritis detection
Knowledge-focused CompletedThis completed study looked at 340 people to understand how certain proteins in the lungs, called autoantibodies, might be linked to the start of rheumatoid arthritis (RA). Researchers collected sputum (mucus from the lungs) from people at risk for RA, those already diagnosed, an…
Sponsor: University of Colorado, Denver • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Rare disease mystery: scientists track GACI and ARHR2 to unlock clues
Knowledge-focused CompletedThis completed study looked at the natural course of two ultra-rare genetic disorders: GACI and ARHR2. Researchers collected medical records and blood samples from 48 affected individuals and their family members. The goal was to better understand how these diseases progress over…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New arthritis drug copy tested in healthy people
Knowledge-focused CompletedThis study tested whether a new version of the arthritis drug abatacept (called KSHB002) works similarly to the approved drug Orencia. Three hundred healthy adults received a single injection of either the new drug or Orencia. Researchers measured drug levels in the blood, checke…
Phase: PHASE1 • Sponsor: Kashiv BioSciences, LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Scleroderma Patients' nutrition under the microscope
Knowledge-focused CompletedThis study followed 150 adults with systemic sclerosis (scleroderma) for two years to track their nutritional health. Researchers measured weight, diet, and disease severity every six months. If malnutrition was found, patients received dietary advice or supplements. The goal was…
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Wearable sensors could revolutionize how we track ankylosing spondylitis
Knowledge-focused CompletedThis study tested whether wearable motion sensors can accurately measure spinal movement in people with ankylosing spondylitis (AS), a condition that causes back pain and stiffness. Forty participants (20 with AS and 20 healthy volunteers) wore sensors while performing everyday m…
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Ultrasound peers at blood vessels in scleroderma patients
Knowledge-focused CompletedThis study used color Doppler ultrasound to look at blood vessels in the belly and hands of 30 adults with systemic sclerosis (scleroderma). The goal was to see how the disease affects larger blood vessels. Participants had an ultrasound scan of arteries in the abdomen and wrist.…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Rheumatism Patients' COVID antibodies under the microscope
Knowledge-focused CompletedThis study followed 163 people with chronic inflammatory rheumatism (like rheumatoid arthritis) who had a recent COVID-19 infection. Researchers measured their antibody levels over two years to see how immunosuppressive drugs affect antibody persistence. The goal was to better un…
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Study reveals how well saudi doctors follow safety rules for common arthritis drug
Knowledge-focused CompletedThis study looked at whether healthcare professionals in Saudi Arabia are aware of and follow safety measures for the drug leflunomide, used for rheumatoid and psoriatic arthritis. Researchers surveyed 302 doctors and pharmacists to see if they received and read safety materials,…
Sponsor: Sanofi • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
New study reveals how brain scans predict surgery outcomes for pituitary tumors
Knowledge-focused CompletedThis study looked at 49 people with masses in the sellar region of the brain (near the pituitary gland). Researchers compared MRI scans before surgery with the final diagnosis after surgery to see how well imaging predicts the type of tumor. The goal was to improve diagnosis and …
Sponsor: Arab Board of Neurosurgery • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Can bone markers predict survival in lung cancer patients?
Knowledge-focused CompletedThis study enrolled 200 adults with lung adenocarcinoma that has spread to the bones. Researchers took bone biopsies, scans, and blood tests to measure bone and metabolic markers. The goal is to see if these markers are linked to how long patients live. This is an observational s…
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Lupus gene study seeks clues in quiet phase
Knowledge-focused CompletedThis study looked at the genes inside B cells from 30 people with inactive lupus and compared them to healthy donors. The goal was to find what makes lupus B cells different, even when the disease is quiet. No treatment was given; this is a pure research study to better understan…
Phase: NA • Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Study reveals why immunotherapy works differently in liver, lung, and brain tumors
Knowledge-focused CompletedThis study looked at medical records of 938 adults with solid tumors who received immunotherapy. Researchers compared how well the treatment worked when cancer had spread to different organs like the liver, brain, lung, or bone. The goal is to understand why some metastatic sites…
Sponsor: Wenlong Zhong, MD • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Pandemic stress hits hard for arthritis patients
Knowledge-focused CompletedThis completed study looked at how the COVID-19 pandemic and social distancing impacted the mental health of 259 adults with chronic inflammatory rheumatism (like rheumatoid arthritis or ankylosing spondylitis). Researchers used questionnaires to measure stress, depression, anxie…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Are women with autoimmune diseases getting the gynecological care they need?
Knowledge-focused CompletedThis study examined whether women with autoimmune diseases or inflammatory rheumatism receive proper gynecological follow-up, including cervical cancer screening and contraception advice. Researchers surveyed 318 women with conditions like lupus, rheumatoid arthritis, and Sjögren…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
New shoulder pain guideline put to the test in GP clinics
Knowledge-focused CompletedThis study tested whether giving general practitioners a simple, evidence-based guideline improves care for people with shoulder pain. 160 adults with shoulder pain took part in Norwegian GP clinics. Researchers measured pain, disability, and quality of life to see if the guideli…
Phase: NA • Sponsor: University of Oslo • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
Thousands tracked: how safe is RINVOQ for arthritis in daily life?
Knowledge-focused CompletedThis study looked at the safety of the drug RINVOQ in over 4,200 Japanese adults with rheumatoid arthritis, a condition causing joint pain and swelling. Researchers reviewed medical records for three years to count serious infections and other side effects that happened during no…
Sponsor: AbbVie • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
New MRI technique reveals hidden details of the achilles tendon
Knowledge-focused CompletedThis study used a special MRI technique to create detailed maps of the Achilles tendon in 121 adults. Researchers compared healthy volunteers to people with a type of arthritis called spondyloarthropathy, both with and without tendon pain. The goal was to better understand tendon…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Massive study reveals hidden dangers of common steroid treatments
Knowledge-focused CompletedThis completed study looked at over 107,000 patients in Germany to understand the long-term side effects of systemic steroids (corticosteroids) used for conditions like asthma, COPD, and arthritis. Researchers compared patients who took steroids with those who did not, tracking r…
Sponsor: GlaxoSmithKline • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Teens' fitness tracked by smartwatches in new digital health study
Knowledge-focused CompletedThis study tested a smartwatch and mobile app platform called Pedi@Ctivity to track physical activity in 362 adolescents, including those with chronic rheumatic disease. The goal was to collect big data and use AI to analyze activity patterns and create personalized exercise prog…
Phase: NA • Sponsor: Istanbul University - Cerrahpasa • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Stiffness check could boost fibroid treatment success
Knowledge-focused CompletedThis study looked at whether measuring the stiffness of uterine fibroids can help predict how well they respond to a non-invasive treatment called MR-HIFU. Forty women with symptomatic fibroids were enrolled. The goal was to improve patient selection so that only those likely to …
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Eye disease biobank seeks clues to uveitis
Knowledge-focused CompletedThis study collected blood, saliva, and eye fluid samples from 343 people with uveitis, an inflammatory eye disease that can cause vision loss. Researchers aimed to learn which genes and other factors might lead to the disease and affect treatment response. Participants were foll…
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Spinal fluid inflammation may explain tethered cord damage in kids
Knowledge-focused CompletedThis study examined spinal fluid from 32 children with tethered spinal cord to see if inflammation plays a role in the condition. Researchers collected fluid samples during surgery and looked for markers of inflammation. The goal was to better understand how the spinal cord gets …
Phase: NA • Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:39 UTC
-
New ultrasound technique reveals how healed tendons perform after ACL repair
Knowledge-focused CompletedThis study looked at 29 people who had ACL surgery using their own hamstring tendons. Researchers used a special ultrasound to check how stretchy the healed tendons were and compared them to the healthy leg. They also tested leg muscle strength to see if tendon quality affects re…
Sponsor: Fatih Sultan Mehmet Training and Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Blood markers may predict arthritis drug success
Knowledge-focused CompletedThis study aimed to find blood markers that can predict whether the drug adalimumab will successfully treat ankylosing spondylitis after 6 months. Researchers analyzed blood samples from 50 adults starting adalimumab for the first time. The goal was to create an algorithm to help…
Phase: NA • Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Scientists probe the root cause of a rare bone marrow disease
Knowledge-focused CompletedThis completed study looked at blood vessel cells from 30 people with primary myelofibrosis, a rare bone marrow disorder. Researchers wanted to see if these cells act like stem cells that could be the origin of the disease. By growing the cells in the lab, they aimed to understan…
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Could the air you breathe trigger arthritis Flare-Ups?
Knowledge-focused CompletedThis completed study investigated whether air pollution affects flare-ups in people with rheumatoid arthritis, ankylosing spondylitis, or psoriatic arthritis. Researchers followed 86 patients for 6 months, asking them to complete weekly questionnaires about their symptoms. They a…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Scientists uncover immune cell clues in rare scleroderma
Knowledge-focused CompletedThis study looked at 235 people to understand how certain immune cells, called innate T cells, might be involved in systemic sclerosis (a rare disease that causes hardening of the skin and organs). Researchers compared patients with systemic sclerosis to those with other autoimmu…
Phase: NA • Sponsor: Poitiers University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Massive study reveals COVID-19 risks for autoimmune patients
Knowledge-focused CompletedThis study looked at over 13,000 people with chronic inflammatory rheumatism or autoimmune diseases who had or were suspected to have COVID-19. Researchers tracked how many developed severe COVID-19 requiring intensive care or leading to death. They also examined risk factors lik…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Small study checks kidney and race impact on transplant drug
Knowledge-focused CompletedThis study looked at how kidney function and race/ethnicity affect the drug treosulfan in 20 patients with AML or MDS getting a stem cell transplant. The goal was to find safe doses for those with kidney problems. It was a small, early-phase study that did not test a new treatmen…
Phase: PHASE1 • Sponsor: medac GmbH • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Scientists map hidden germs in kids with cancer
Knowledge-focused CompletedThis study looked at the tiny organisms (bacteria and fungi) living in the mouth and nose of children with leukemia or those getting a bone marrow transplant. Researchers wanted to see how these germ communities change during chemotherapy. The goal was to learn more, not to test …
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Blood cancer enzyme deficiency explored in new study
Knowledge-focused CompletedThis study looked at how often people with certain blood cancers or related conditions have an acquired deficiency of an enzyme called pyruvate kinase, which can cause anemia. Researchers took a single blood sample from 18 participants to measure enzyme activity and check for rel…
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Gum lesion study reveals immune cell differences
Knowledge-focused CompletedThis study looked at immune cells in a non-cancerous gum growth called peripheral giant cell granuloma (PGCG) and compared them to healthy gum tissue from the same 28 patients. Researchers used special staining to count different types of immune cells. The goal was to better unde…
Sponsor: Ataturk University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
8,000 kidney tumor samples collected to unlock cancer clues
Knowledge-focused CompletedThis completed research study collected and stored tumor tissue, blood, and urine samples from 8,000 children and young adults with kidney tumors. The goal was to help scientists study DNA changes and find biomarkers that could improve understanding of these cancers. No treatment…
Sponsor: Children's Oncology Group • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Screen time toll: study links phone & game addiction to poor sleep and pain in students
Knowledge-focused CompletedThis study looked at 194 university students aged 18-30 to see how smartphone and digital game addiction relates to physical activity, sleep quality, stress, fatigue, and muscle or joint pain. Participants filled out questionnaires about their habits and health. The goal is to un…
Sponsor: Istanbul University - Cerrahpasa • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Tiny particles may hold clues to autoimmune diseases
Knowledge-focused CompletedThis study looked at tiny particles called microparticles in the blood and urine of people with lupus or scleroderma. Researchers wanted to see if these particles could help explain how these diseases work and possibly lead to better diagnosis or treatment. Over 200 adults partic…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Brain radiation may erase personal memories, study warns
Knowledge-focused CompletedThis study looks at how radiation therapy for brain tumors like meningioma or pituitary adenoma might affect autobiographical memory—the memories of your life events. Researchers will ask 17 patients to complete memory tests one and two years after treatment. The goal is to see i…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Lupus clue: can a heart drug reveal hidden disease markers?
Knowledge-focused CompletedThis small pilot study looked at whether clopidogrel, a drug that stops blood clots, could lower a substance called sCD40L in people with lupus. Lupus is an autoimmune disease where the body attacks itself. The study involved 18 adults with lupus and measured sCD40L levels in the…
Phase: PHASE1, PHASE2 • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Rheumatoid arthritis Patients' arm function under the microscope
Knowledge-focused CompletedThis completed study from Turkey looked at how well rheumatoid arthritis patients can use their arms and hands. Researchers tested 26 patients using a pegboard and ring test for arm exercise, a hand dynamometer for grip strength, and a daily living test. The goal was to better un…
Sponsor: Kirsehir Ahi Evran Universitesi • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Mold infection risk in kids with leukemia: a 14-year review
Knowledge-focused CompletedThis study looked back at 621 children in Denmark who had chemotherapy for acute leukemia between 2008 and 2022. The goal was to find out how many got serious mold infections and what factors made it more likely. The results will help doctors better protect children during treatm…
Sponsor: University of Southern Denmark • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
New study aims to predict which fibroids respond best to Non-Invasive ultrasound treatment
Knowledge-focused CompletedThis study looked at 40 women with symptomatic uterine fibroids to understand why MR-guided focused ultrasound (HIFU) works better for some than others. Researchers used MRI and contrast-enhanced ultrasound to measure fibroid blood flow, stiffness, and other features before treat…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Scientists probe Immune-Vessel link in rare scleroderma
Knowledge-focused CompletedThis study looked at how blood vessel cells and immune cells talk to each other in people with systemic sclerosis, a rare autoimmune disease that causes skin hardening and organ damage. Researchers collected blood samples and skin biopsies from 350 participants to measure a speci…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Could your diet trigger lupus? new study investigates
Knowledge-focused CompletedThis study measured phytoestrogens (plant-based compounds) in the blood and urine of 63 premenopausal women with active lupus, other autoimmune diseases, or no disease. Researchers also asked about diet and measured estradiol levels. The goal was to see if these dietary compounds…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
New tool helps older leukemia patients and doctors talk better
Knowledge-focused CompletedThis study tested a tool called UR-GOAL to help older patients with acute myeloid leukemia (AML), their caregivers, and their doctors communicate better and make decisions together. It involved 161 participants aged 60 and older. The goal was to see if the tool improved shared de…
Phase: NA • Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Lupus skin study reveals why patients skip meds
Knowledge-focused CompletedThis study looked at 202 adults with cutaneous lupus to see how well they follow their treatment plans and how satisfied they are with their care. Researchers used questionnaires to measure adherence, beliefs about medicine, anxiety, depression, and quality of life. The goal is t…
Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Which health survey works best for joint disease? large study aims to find out
Knowledge-focused CompletedThis completed study looked at nearly 7,000 adults with inflammatory joint diseases like rheumatoid arthritis and psoriatic arthritis. Researchers compared two versions of a standard health survey (EQ-5D-3L and EQ-5D-5L) to see which one better measures health and quality of life…
Sponsor: Karolinska Institutet • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Can a simple blood test help rheumatoid arthritis patients get the right drug?
Knowledge-focused CompletedThis study looked at whether measuring drug levels and anti-drug antibodies in the blood of rheumatoid arthritis patients can help doctors make better treatment decisions. 52 patients starting adalimumab or certolizumab were randomly assigned to have their test results shared wit…
Phase: NA • Sponsor: University of Manchester • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Scientists probe immune Cells' role in scleroderma blood vessel injury
Knowledge-focused CompletedThis completed study looked at how certain immune cells (T cells and NK cells) might damage blood vessels in people with systemic sclerosis, a rare autoimmune disease. Researchers analyzed blood samples from 30 participants to measure a protein called Fractalkine and study cell i…
Phase: NA • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Scientists analyze genetic markers in stored samples to boost personalized medicine
Knowledge-focused CompletedThis study looked at DNA methylation patterns in stored samples from 90 patients with rare skeletal disorders, sarcomas, or inflammatory arthritis. The goal was to better understand these patterns and explore their potential for diagnosis and treatment. The research aimed to impr…
Sponsor: Istituto Ortopedico Rizzoli • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Blood sample study explores new target for inflammatory arthritis
Knowledge-focused CompletedThis study looked at blood samples from 24 people with axial spondyloarthritis (a type of inflammatory arthritis) and 12 healthy volunteers to understand how a receptor called KIR3DL2 contributes to inflammation. Researchers also tested whether a drug called IPH4102 could reduce …
Phase: NA • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
New tool may predict who will suffer after achilles surgery
Knowledge-focused CompletedThis study looked at 489 patients who had Achilles tendon surgery to find out what factors lead to moderate-to-severe pain in the first 24 hours. Researchers created a prediction tool (nomogram) based on these risk factors. The goal is to help doctors identify high-risk patients …
Sponsor: Min Li • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Study reveals hidden toll of skin changes in rare disease
Knowledge-focused CompletedThis study looked at how skin changes from systemic sclerosis affect a person's feelings about their appearance. Researchers compared 170 patients with the disease to healthy people using surveys about body image and emotional distress. The goal was to understand the burden of th…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Keyhole surgery blood loss study compares tying techniques
Knowledge-focused CompletedThis study looked at 60 women aged 35 to 60 who had a hysterectomy (removal of the uterus) through small cuts in the belly (laparoscopy). The goal was to compare two different methods of tying off the uterine arteries to see which one led to less blood loss during surgery. The re…
Phase: NA • Sponsor: Mostafa Bahaa • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Comic book teaches kids to beat pain fears
Knowledge-focused CompletedThis study tested a school program called SocLaLola that uses a comic book to teach children aged 8-11 about pain. The goal was to see if it improves kids' understanding of pain and reduces their fear of moving. Eighty-two students from two primary schools took part. The program …
Phase: NA • Sponsor: Universitat de Lleida • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
AI analyzes 10,000 patient records to predict head and neck cancer recurrence
Knowledge-focused CompletedThis completed study used artificial intelligence to examine electronic health records from 10,000 head and neck cancer patients. The goal was to create models that can predict the risk of cancer coming back or progressing, and to identify which patients might live longer after i…
Sponsor: Savana Research • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
New study links common arthritis treatments to diabetes risk
Knowledge-focused CompletedThis observational study followed 198 adults aged 50–85 with giant cell arteritis or polymyalgia rheumatica to understand how common treatments (glucocorticoids and interleukin-6 inhibitors) affect diabetes risk. Researchers tracked blood sugar levels and other markers over time.…
Sponsor: Salome Kristensen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC
-
Personalized mutation tracking could spot relapse sooner in bone marrow cancer patients
Knowledge-focused CompletedThis study looked at 308 people with myelodysplastic syndromes (MDS) who had a stem cell transplant. Researchers identified each patient's unique genetic mutations and then monitored those mutations in blood and bone marrow samples after transplant. The goal was to see if rising …
Sponsor: Nordic MDS Group • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Which lung test is best for scleroderma patients?
Knowledge-focused CompletedThis study compared two commercially available devices that measure how well the lungs transfer nitric oxide and carbon monoxide. Nine adults with systemic sclerosis and related lung disease took part. Each person was tested with both devices in random order to see if the results…
Sponsor: Holger Dressel • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New drug RAB001 takes first step: safety check in healthy volunteers
Knowledge-focused CompletedThis early-stage study tested the safety and tolerability of a new drug called RAB001 in 16 healthy adults. Researchers gave single and multiple injections at two dose levels to see how the body handles the drug and if it causes side effects. This is a first step before testing t…
Phase: PHASE1 • Sponsor: ZhongShan LaiBo RuiChen BioMedicine Co.,Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Scientists hunt for hidden signs in blood cancers to personalize treatment
Knowledge-focused CompletedThis study collected blood, bone marrow, skin, and cheek cell samples from 650 adults with acute leukemia, myelodysplastic syndromes, or myeloproliferative disorders. Researchers analyzed the samples to find genetic, epigenetic, and drug sensitivity patterns that might predict ho…
Phase: NA • Sponsor: Institut Paoli-Calmettes • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Tiny study probes Tofacitinib's hidden effects on body composition
Knowledge-focused CompletedThis completed study looked at how tofacitinib, a rheumatoid arthritis drug, changes body fat, muscle, and bone density in 10 patients. Researchers measured visceral fat, lean mass, and bone marrow fat before and after treatment. The goal was to gather early data, not to prove th…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
App and wearable track daily struggles of arthritis patients
Knowledge-focused CompletedThis study tested whether a smartphone app and a wearable activity tracker are practical and acceptable for people with inflammatory rheumatic diseases like rheumatoid arthritis and spondyloarthritis. Over 14 days, 50 participants answered short surveys on their phone and wore a …
Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Scientists examine bone tissue to uncover causes of hip joint decay
Knowledge-focused CompletedThis study looked at bone tissue from 34 men who had hip replacement surgery due to femoral head necrosis (bone death in the hip joint). Researchers used advanced imaging and spectroscopy to identify changes in bone structure and composition. The goal was to better understand wha…
Phase: NA • Sponsor: Lille Catholic University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:10 UTC
-
New study tracks COVID vaccine durability in chronic illness patients
Knowledge-focused CompletedThis completed study followed 360 adults and children with chronic respiratory and other medical conditions to see how their immune systems responded to COVID-19 vaccines over 18 months. Researchers measured antibody, T cell, and B cell levels before vaccination and every 3 month…
Sponsor: National Jewish Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:10 UTC
-
New tool aims to give older leukemia patients a stronger voice in treatment choices
Knowledge-focused CompletedThis pilot study tested a communication tool called UR-GOAL in 15 older adults (age 60+) with newly diagnosed acute myeloid leukemia (AML), along with their caregivers and doctors. The tool helps patients share their preferences and goals, so treatment decisions better match what…
Phase: NA • Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
Nurse detectives: early warning system for arthritis flares?
Knowledge-focused CompletedThis study looked at whether regular nurse check-ins could spot the return of rheumatoid arthritis symptoms sooner than standard doctor visits. 51 adults with controlled arthritis on rituximab took part. The goal was to see if nurses could detect early signs of a flare, potential…
Phase: NA • Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Better scans could help measure spine fusion in ankylosing spondylitis
Knowledge-focused CompletedThis study looks at whether CT scans are better than regular X-rays for measuring how the spine stiffens and fuses in people with ankylosing spondylitis. Researchers will follow 63 adults over 4 years, using scans, blood tests, and flexibility measurements. The goal is to find a …
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Cuddle cure: skin contact after C-Section boosts breastfeeding and calms nerves
Knowledge-focused CompletedThis study tested whether holding a newborn skin-to-skin right after a C-section (within 5 minutes) or within the first hour helps with breastfeeding, reduces anxiety, and keeps mom and baby healthy. 92 mothers and their newborns took part. The results showed that early contact c…
Phase: NA • Sponsor: Çankırı Karatekin University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Blood test could predict leukemia survival
Knowledge-focused CompletedThis study tests whether measuring two substances in the blood—FLT3L and IL-6—during chemotherapy can help predict survival in people with acute myeloid leukemia (AML). Researchers will track 201 newly diagnosed AML patients across 25 French hospitals. The goal is to confirm that…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Ultrasound reveals muscle differences in hip pain patients
Knowledge-focused CompletedThis study used ultrasound to measure the thickness of certain hip muscles in 60 adults with hip pain on one side (Greater Trochanteric Pain Syndrome) and compared them to healthy people. The goal was to see if muscle thickness differs between the groups and to check for related …
Sponsor: Ankara Etlik City Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Lupus Patients' Pill-Taking habits under the microscope
Knowledge-focused CompletedThis study looked at how often people with active lupus take their medication as prescribed. Researchers measured blood levels of hydroxychloroquine in 307 patients to find out who was skipping doses. The goal was to understand how common non-adherence is, especially in those wit…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Combining traditional chinese medicine with standard care may ease RA and depression
Knowledge-focused CompletedThis completed study looked at whether adding an integrated care model—including traditional Chinese medicine—to standard treatment could lower inflammation and depressive symptoms in people with rheumatoid arthritis. Researchers measured blood markers of inflammation and used a …
Phase: NA • Sponsor: Dalin Tzu Chi General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Tiny study tests best way to fill gaps after tooth extraction and implant
Knowledge-focused CompletedThis small pilot study looked at 8 adults who needed a single tooth replaced with an immediate dental implant. Researchers compared two methods to manage the gap between the implant and the cheek bone: a bone mineral graft or a soft tissue graft. They used scans and X-rays to mea…
Phase: NA • Sponsor: Saint-Joseph University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Fertility after fibroid embolization: new data from 46 women
Knowledge-focused CompletedThis study looked back at 46 women who had a procedure called uterine artery embolization to treat fibroids. The goal was to see how often women later had a baby and what pregnancy complications occurred. The researchers reviewed medical records from one hospital in France to gat…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Blood test may reveal hidden inflammation in back pain patients
Knowledge-focused CompletedThis study looked at 65 adults with ankylosing spondylitis, a type of arthritis that affects the spine. Researchers wanted to see if a blood test called the CALLY index could measure inflammation better than patient-reported symptoms. They reviewed medical records and compared th…
Sponsor: Bursa City Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Study questions need for frequent blood tests in common arthritis drug
Knowledge-focused CompletedThis study looked at over 2,400 people with rheumatic diseases who take methotrexate. Researchers compared those who had standard lab monitoring to those who had fewer blood tests. The goal was to see if reduced monitoring is as safe in terms of preventing organ damage or death.
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Watchful waiting: new study tracks rare tumor growth without immediate treatment
Knowledge-focused CompletedThis study followed 100 adults with a rare, non-cancerous tumor called peripheral primitive fibromatosis. Instead of treating everyone right away, doctors monitored patients closely to see how the tumors behaved over three years. The goal was to learn which factors might predict …
Phase: NA • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
New breathing test studied in spine arthritis patients
Knowledge-focused CompletedThis study looked at chest expansion, lung function, and a new measure of breathing muscle strength called the S-index in 52 people with radiographic axial spondyloarthritis and healthy controls. The goal was to see if these measures differ between the two groups and if the S-ind…
Sponsor: Gazi University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Knee surgery drain debate: new study compares blood loss with and without drain
Knowledge-focused CompletedThis study looked at whether placing a drain after knee replacement surgery affects how much hemoglobin drops and whether patients need a blood transfusion. 102 patients were randomly assigned to get a drain or not. The goal is to see if drains help or hurt in terms of blood loss…
Phase: NA • Sponsor: Shifa International Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
New study tracks hidden heart and bone risks in Cushing's disease
Knowledge-focused CompletedThis study followed 80 people with newly diagnosed Cushing's disease for three years to see how the disease affects the heart, bones, metabolism, and quality of life. Researchers used blood tests, heart scans, bone density tests, and questionnaires to track complications before a…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
Can a video call help blood cancer patients prepare for tough decisions?
Knowledge-focused CompletedThis study tested whether a telehealth program could help older patients (60+) with acute myeloid leukemia or myelodysplastic syndrome discuss and document their future medical wishes. Researchers enrolled 36 patients, caregivers, and clinicians to see if the program was easy to …
Phase: NA • Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Scientists probe genetic roots of Cold-Triggered hives
Knowledge-focused CompletedThis study looks at why some people develop hives from physical triggers like cold, pressure, or sunlight. Researchers will test participants' skin reactions and collect blood and genetic samples to understand the role of immune cells and genes. The goal is to uncover the underly…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
COVID-19's hidden toll on autoimmune patients revealed
Knowledge-focused CompletedThis study followed 293 people with autoimmune diseases and healthy volunteers to see how COVID-19 infection or vaccination affects their immune system, inflammation, and blood vessels. Participants were grouped based on their COVID-19 history and had up to 5 visits over 12-18 mo…
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Scleroderma hand study reveals key differences in disability
Knowledge-focused CompletedThis study looked at 30 adults with scleroderma, an autoimmune disease that often causes hand stiffness and disability. Researchers measured how much movement was limited in each hand to compare the dominant and non-dominant sides. The goal was to better understand hand function …
Phase: NA • Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Immune clues in rare lung disease explored
Knowledge-focused CompletedThis completed study looked at how the immune system might affect the outlook for people with pulmonary arterial hypertension (PAH). Researchers took blood and skin samples from 629 participants with different types of PAH to search for specific antibodies. The goal was to better…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
How many autoimmune patients try alternative therapies? new study counts
Knowledge-focused CompletedThis completed study surveyed 121 adults with autoimmune diseases like lupus, Sjögren's syndrome, or scleroderma. Participants filled out a questionnaire about their use of alternative medicines. The goal was to find out how common these practices are in this patient group.
Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Can MRI replace CT scans for lung fibrosis in scleroderma?
Knowledge-focused CompletedThis study tested whether a special MRI technique can measure lung stiffness in people with scleroderma, a disease that often causes lung scarring. Researchers enrolled 24 adults and compared MRI results to standard lung function tests. The goal was to see if MRI could offer a sa…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Researchers aim to create a universal checklist for scleroderma
Knowledge-focused CompletedThis study aimed to create a standard set of items, called an ICF core set, to describe the health and functioning of people with systemic sclerosis (scleroderma). Researchers gathered input from 100 patients and experts to identify the most important aspects of the disease. The …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Eye scan may forecast vision after brain surgery
Knowledge-focused CompletedThis study tested whether a type of eye scan called OCT-angiography can predict how well vision will recover after surgery to remove a pituitary tumor. Researchers compared the scan results with standard vision tests in 21 patients. The goal was to see if the scan could serve as …
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Healthy volunteers needed to test new myelofibrosis drug's absorption
Knowledge-focused CompletedThis study looked at how well two different capsule forms of TP-3654 are absorbed by the body and whether taking them with food changes absorption. It involved 24 healthy adults and was completed. The results will help design future studies for people with myelofibrosis, a bone m…
Phase: PHASE1 • Sponsor: Sumitomo Pharma America, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Lupus lung link: new study reveals hidden breathing problems
Knowledge-focused CompletedThis study looked at how lupus affects breathing, daily activity, and tiredness. Researchers compared 50 people with lupus to healthy volunteers using breathing tests, a 6-minute walk, and questionnaires. The goal was to find early signs of lung problems so doctors can treat them…
Sponsor: Melis Usul • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Tiny study hopes to simplify muscle testing for rare muscle disease
Knowledge-focused CompletedThis study looked at a new way to measure muscle function in people with inflammatory myopathies (diseases that cause muscle weakness). Researchers compared a simple test called the Myositis Functional Index-3 with advanced computerised muscle testing. They also tested whether a …
Phase: NA • Sponsor: Federal University of Espirito Santo • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
5-Year lupus drug safety check: benlysta under the microscope
Knowledge-focused CompletedThis 5-year study tracked over 3,000 adults with active lupus to see how safe and effective Benlysta (belimumab) is compared to standard care alone. Researchers monitored serious infections, cancers, and other side effects. The goal was to gather real-world data to help doctors a…
Sponsor: GlaxoSmithKline • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:04 UTC
-
Lupus study aims to unlock secrets of immune system attacks
Knowledge-focused CompletedThis study looked at how the immune system behaves in people with lupus (SLE) and mixed connective tissue disease (MCTD). Researchers measured immune cell responses and tracked disease activity over time. The goal was to better understand these long-term autoimmune diseases, whic…
Sponsor: University of Miami • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Coaching teens through the scary leap to adult healthcare
Knowledge-focused CompletedThis pilot study tested whether a transition coach can help 16-17 year olds with Juvenile Idiopathic Arthritis or Inflammatory Bowel Disease move from pediatric to adult care. The coach met with each teen for 8 one-hour sessions covering self-advocacy, medication management, and …
Phase: NA • Sponsor: McMaster University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Apple watches reveal surprising effects of air purifiers on your body
Knowledge-focused CompletedThis study tested whether using an indoor air purifier changes health measures like heart rate, sleep, and oxygen levels. 42 healthy adults wore Apple Watches while using a real or fake (sham) air purifier at home. The goal was to see if cleaner air makes a short-term difference …
Phase: NA • Sponsor: New York University Abu Dhabi • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Can better scans improve breast cancer bone treatment?
Knowledge-focused CompletedThis study looked at 28 women with breast cancer that spread to their bones. Researchers compared two types of scans—PET-CT and whole-body MRI—to see if they agree on whether the bone tumors are stable, improving, or getting worse. The goal is to find a reliable way to monitor tr…
Sponsor: Centre Oscar Lambret • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Lupus Patients' quality of life under the microscope in new study
Knowledge-focused CompletedThis study followed 356 adults with lupus over time to see how the disease impacts their quality of life. Participants filled out questionnaires about their symptoms, fatigue, mood, and daily activities. The goal was to better understand what factors affect well-being in lupus, w…
Phase: NA • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Jumping knee injury study reveals hidden movement differences
Knowledge-focused CompletedThis study looked at how people with patellar tendinopathy (a common knee overuse injury in sports) move their legs during side-cutting, compared to healthy individuals. Sixty participants—30 with the injury and 30 without—performed side-cutting tasks while motion capture cameras…
Sponsor: Peking University Third Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Missing hand muscle may shield against dupuytren disease
Knowledge-focused CompletedThis study compared 243 people with and without Dupuytren disease to see if having the palmaris longus tendon (a small hand tendon not everyone has) is linked to the condition. Researchers used simple hand tests and ultrasound to check for the tendon. The goal is to understand if…
Phase: NA • Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Can a simple test predict who will respond to this sarcoma drug?
Knowledge-focused CompletedThis study aims to find biological markers that can predict whether the drug trabectedin will work in patients with certain types of soft-tissue sarcoma. Researchers will collect tumor biopsies and blood samples from 29 participants before and during treatment. The goal is to use…
Phase: NA • Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC
-
Sexual health in arthritis patients under the microscope
Knowledge-focused CompletedThis completed study examined the link between erectile dysfunction, nerve pain, disease activity, and daily function in 90 men with axial spondyloarthritis (a type of arthritis affecting the spine). Participants were either on anti-TNF drugs, NSAIDs, or were healthy volunteers. …
Sponsor: Altuğ Güner • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
Injured your good hand? your other hand might get better!
Knowledge-focused CompletedThis study looked at 40 adults who had to wear a splint or cast on their dominant hand for 6 weeks after an injury. The goal was to see if being forced to use the non-dominant hand actually improves its function. Researchers measured hand skills and disability levels to understan…
Sponsor: Gazi University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
Lupus patients get custom steroid tapering plan in new study
Knowledge-focused CompletedThis study tested a personalized way to reduce steroid doses in 72 lupus patients. Doctors used blood tests and regular check-ups over 3 months to safely lower prednisone. The goal was to find the best tapering schedule for each person, minimizing side effects while controlling t…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
Can better Doctor-Patient talks improve rheumatoid arthritis care?
Knowledge-focused CompletedThis completed study tested whether training rheumatology clinicians in shared decision making helps veterans with rheumatoid arthritis. About 900 patients from VA clinics took part. The training taught doctors to acknowledge treatment options and involve patients in choices. Res…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC